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Abstract: In recent years antimicrobial peptides have gained a lot of attention
due to their potential as a new generation of antibiotics combating the growing
problem of antibiotic resistance. It is believed that the amphipathic structure of
cationic peptides is a key feature for antimicrobial activity, and that this enables
them to interact with the bacterial cell membrane. The conformational space
of a range of cationic tripeptides have in this project been studied in solvent
using density functional theory and molecular dynamics simulations. The results
indicate that the cationic tripeptides are able to change between different, but
equally stable, conformations that are both amphipathic and non-amphipathic,
a property referred to as face flipping. Based on this, face flipping is proposed
to be a key feature for the membrane interaction mechanism. The tripeptides
mode of interaction was therefore studied with cellular model systems in more
detail using MD simulations. The results show that the peptides first interact
with the negatively charged head groups of the membrane with their cationic
charges and then flip the hydrophobic groups into the membrane bilayer. The
results thus provide strong support to the face flipping hypothesis.
A problem with antimicrobial peptides is that oral administration is diffi-
cult due to the degradation by digestive enzymes. The stability towards chy-
motryptic degradation has therefore been investigated by probing the S1, S1’
and S2’ binding pockets with unnatural amino acid side chains. The effect
of different side chain substitutions were examined by combining isothermal
titration calorimetry, crystallization experiments and extensive molecular mod-
elling. Through these studies it was possible to investigate the preferential
binding of several relevant unnatural amino acid side chains to the subsites of
chymotrypsin. Important structural and mechanistic features were revealed in
a fashion not feasible through the use of native peptide substrates. It was also
found that proteolytic stability can be controlled not only by probing the S1
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Ψ Many electron wave function
AO Atomic orbital
Agp L-2-amino-(3-guanidino)propanoic acid
Amphiphile Chemical compound possessing both hydrophilic and




ATTC American type culture collection
Bip L-biphenyl alanine
Bn Benzyl
BPTI Bovine Pancreatic Trypsin Inhibitor





DFT Density functional theory













FISA Hydrophilic solvent accessible surface area
Force field A sum of different molecular mechanics terms expressing the
energy of a system




GGA Generalized gradient approximaton
Gpp L-2-amino-3-(4-guanidinophenyl)propanoic acid
GRP Generalized random phase
Har L-2-amino-(4-guanidino)hexanoic acid
HF Hartree-Fock
ITC Isothermal titration calorimetry
LSDA Local spin density approximation
MBPT Many-body perturbation theory
MC Monte carlo
MD Molecular dynamics
MIC Minimal inhibitory concentration
MR Molecular replacement




PCM Polarizable continuum model
PE Phosphatidylethanolamine
Ph Phenyl
Phatogen Organism, usually microorganism, that causes disease
PISA π component of the solvent accessible surface area
POPE 1-palmitoyl-2-oleoyl-glycero-3-phosphoethanol-amine
PG Phosphatidylgylcerol
PRCG Polak-Ribiere-type conjugate gradient
QM Quantum mechanics
RBD Rigid-body docking







; di = |xi − x′i|
RP-HPLC Reversed Phase High Performance Liquid Chromatography
SA Simulated annealing
SASA Solvent accessible surface area
SCF Self-Consistent Field
SCRF Self-consistent reaction field
Tbt β-(2,5,7-tri-tert-butylindol-3-yl)alanine
UFF Universal Force Field
VRE vancomycin-resistant Enterococcus faecium
XP Extra precision (in Glide docking)
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"It would be possible to describe everything scientifically, but it would make no sense; it






In 1929 a British scientist named Alexander Flemming characterized an antibac-
terial product of the fungus Penicillium chrysogenum as the β-lactam antibiotic
penicilllin G. He had discovered what became the first clinically effective antibi-
otic. In 1945 penicillin became available for general use, and pharmaceutical
companies soon began to look for other antibiotics, which in turn led to the
discovery of drugs that revolutionized treatment of infectious diseases [1].
Throughout the years many effective drugs and vaccines have been discov-
ered or synthesized. However, in spite of the availability of effective drugs and
vaccines, the battle against infectious diseases is far from being over. The emer-
gence and spread of antimicrobial resistance is now threatening to undermine
the ability to treat infections and save lives [2]. The drug resistance itself is an
outcome of natural selection and should perhaps be viewed as an expected phe-
nomenon of the Darwinian biological principle of ”survival of the fittest”. The
need for new and better drugs against microorganisms like bacterias, viruses and
fungous is increasing rapidly and the ongoing race between new drugs and an-
timicrobial resistance seems like a neverending process. Even though resistance
was recognized early it is only just beginning to be considered as a societal issue
and, in economic terms, as a negative externality in the health care context. It
has recently been described as a threat to global stability and national security
[3]. Some pathogens have now developed resistance to all known antimicrobial
agents. Among these are several isolates of methicillin-resistant Staphulococcus
aurerus (MRSA), vancomycin-resistant Enterococcus faecium (VRE) and iso-
lates of Mycobacterium tuberculosis [1]. However, the biggest concern today is
that the pipeline of new drugs is running dry and the incentives to develop new
antimicrobials to address the global problems of drug resistance are weak [3].
One of the main reasons for resistance is overuse of drugs and antimicrobial
resistant microorganisms typically emerge from hospitals. Due to these seri-
ous problems the world health organization (WHO) started an implementation
workshop on the global strategy for containment of antimicrobial resistance in
November 2002. Guidelines are being provided to slow the emergence and re-
duce the spread of antimicrobial resistant microorganisms. Some of the key
points made by the WHO framework are to slow the emergence and reduce the
spread of resistance through [3]:
• Reducing the disease burden and the spread of infection.
• Improving access to appropriate antimicrobials.
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• Improving use of antimicrobials to slow the emergence and reduce the
spread of antimicrobialresistant microorganisms.
• Strengthening health systems and their surveillance capabilities.
• Enforcing regulations and legislation.
• Encouraging the development of appropriate new drugs and vaccines.
The development of new and appropriate drugs are clearly necessary, but as the
pipeline of new drugs is running dry, this is today a challenging task.
1.2 Antimicrobial peptides
Antimicrobial peptides (AMPs), which sometimes goes under the name host
defense peptides, are evolutionarily conserved components of the innate im-
mune system which are found among a wide variety of organisms as their first
line of defense [4]. Antimicrobial peptides are a unique and diverse group of
molecules typically ranging from 12 to 100 amino acids having a net positive
charge along with an amphiphillic structure. These AMPs have been isolated
from single-celled microorganisms, plants, amphibians, birds, fish, mammals
(including humans), insects and other invertebrates [5, 6]. In the Antimicrobial
Peptide Database there are currently (August, 2009) reported 1474 such pep-
tides with an average length of 29.87 amino acids and an average charge of 3.81
[6, 7]. Among these AMPs 5.83% are antiviral, 29.3% antifungual, 6.37% anti-
cancer (antitumor) and 77.81% are antibacterial. Even though it is found that
such peptides may have a direct effect on the microbe, by damaging or destabi-
lizing the bacterial, fungal, or viral membrane or acting on other targets, they
appear to be broadly involved in the orchestration of the innate immune and
inflammatory response [8].
Despite the AMPs similar general physical properties it appears that there
are very limited sequence homologies and a wide variety of secondary struc-
tures with at least four major themes. To date the most prominent structures
reported are amphiphillic peptides with two to four β-strands, amphipathic α-
helices, loop structures, and extended structures [9, 10]. Of special interest
is the fact that cationic AMPs (CAPs) have been found to show an unusual
broad antimicrobial activity spectrum, and therefore constitute an attractive
class of compounds for further development against bacterial strains resistant
to the antibiotics of today. Their amphiphillic and positively charged structure
have been proposed to interact with the negatively charged components of the
cytoplasmic membrane of bacteria and therebye increasing the permeability to
ions and solutes, which in turn may lead to cell death [11]. It is believed that
this takes place via a disruption of the membrane, either via an ordered pore
formation, which is described by the barrel-stave model and the toroidal model
[12], or in a disordered manner, where the peptides interact with the surface
and destabilize the membrane, resulting in collapse, which often is referred to
as the carpet model [13]. A combination of the ordered and disordered mecha-
nism has also been suggested as a possible mechanism [15–18]. The models are
illustrated in Figure 1.1. All these models require, either explicitly or implic-
itly, that a certain threshold concentration, given as lipid:peptide (L:P) ratio,
in the membrane must be crossed for disruption to occur. In some cases the
14
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Figure 1.1: Illustration of proposed mechanisms of antimicrobial peptidemediated
membrane disruption (adapted from Melo et al [14]): a) The barrel-stave pore, b) the
carpet mechanism, c) the toroidal pore and d) the disordered toroidal pore.
threshold concentration can be as high as one peptide molecule per six phospho-
lipid molecules, which is close to full membrane saturation [19]. The minimum
inhibitory concentration (MIC) for AMPs are typically in the low micromolar
range, and scepticism has arisen regarding the relevance of these thresholds and
their importance in vivo [20, 21]. The macroscopic effects of crossing the MIC
are easily observed by for example cell lysis, loss of viability or bacteriostasis
(a phase in which microbial organisms are prevented from undergoing further
cell growth, without being killed) [22]. It is however not clear if the final killing
event of CAPs is due to damaged cytoplasmic membrane or a combination of
membrane permeabilization and peptide interactions with intracellular targets
[23, 24]. Thus, the exact mechanism of interaction is still not known in de-
tail, and the models proposed so far might be too rigid to fully account for the
many interactions that these molecules can establish in a complex membrane
environment. This has previously been demonstrated with molecular dynamics
simulations of AMPs interacting with phospholipid bilayers [25–27]. The obser-
vations from these studies indicated multiple co-existent structures, non-specific
peptide-peptide interactions and membrane perturbation dictated by stochastic
events. This indefinite behavior has the advantage that the bacteria seem to
find it hard to circumvent the AMP action and the evolution of resistance is
consequently more difficult [28].
Even though the mechanisms of AMPs action are not always precisely de-
fined, some main factors emerge that lead to high levels of binding and selectivity
towards bacteria (Table 1.1) [29]. Peptide cationic charges are considered as one
of the key features for stronger interaction with the anionic bacterial membrane.
Further enrichment of the peptides with hydrophobic amino acids together with
cationic residues have been found to correlate with stronger partitioning to mem-
branes, but also with higher levels of hemolytic activity. Another key feature is
the amphipathicity of the peptides. During membrane interaction, AMPs adopt
15
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Table 1.1: Antimicrobial peptides and bacterial characteristics [29].
Characteristic Observed effect
Peptide:
Cationic charge Stronger interaction with anionic bacterial membrane.
Hydrophobicity Stronger portioning to membranes.
Higher levels of hemolytic activity.
Amphipathicity Higher levels of peptide internalization and membrane
perturbation.
Bacteria:
Anionic charge More fluid bilayers which are more susceptible to
binding and probable disruption by cationic AMPs.
Transmembrane potential Promotes AMP interaction while acting as a
potential driving force for for peptide insertion
and translocation.
Bilayer asymmetry Differences in inner and outer leaflet composition
provides a basis for further discrimination.
preferred conformations that frequently involve segregation of polar and apolar
residues to opposite regions of the structure. Amphipathic structures therefore
leads to higher levels of peptide internalization and membrane perturbation.
In contrast to mammalian membranes, which mainly consist of neutral phos-
pholipids enriched with sterols, the bacterial membranes are composed of a
large proportion of anionic phospholipds. This feature makes cationic peptides
more target specific towards bacterial membranes, where they also can enter
the fluid bilayers more easily compared with mammalian membranes[29]. A
schematic presentation of the bacterial cell membranes for Gram-positive and
Gram-negative bacteria is illustrated in Figure 1.2. The main difference between
Figure 1.2: Schematic presentation of molecular organization of bacterial cell mem-
branes. (Adapted from Lohner et al. [30])
these two is that Gram-negative bacteria consist of an outer membrane with
an asymmetric distribution of lipopolysaccharides (LPS) and phospholipids,
predominantly phosphatidylethanolamines (PE), and a cytoplasmic membrane.
16
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Gram-positive bacteria on the other hand only have a cytoplasmic membrane,
protected by a peptidoglycan layer, which is also found in the periplasmic space
of Gram-negative bacteria. Common for both bacteria is that phosphatidylgyl-
cerol (PG) is the most abundant negatively charged phospholipid species [31].
The phospholipid composition in Gram-positive bacteria has further been found
to vary more from one species to another compared with Gram-negative bacte-
ria [32]. Some examples of the membrane composition of selected Gram-positive
and Gram-negative bacteria are shown in Table 1.2. Detailed knowledge of the
Table 1.2: Phospholipid composition of selected Gram-negative and Gram-positive
bacteriaα,β .
Bacteria species PGf DPGg L-lysl PGh PEi Others
Gram-negative
Escherichia coli OMa 3 6 0 91 0
CMb 6 12 0 82 0
Pseudomonas cepacia OM 13 0 0 87 0
CM 18 0 0 82 0
Salmonella typhimurium OM 17 2 0 81 0
CM 33 7 0 60 0
Erwinia carotovora OIMc 14 8 0 78 0
Gram-positive
Staphylococcus aureus CM 57 5 38 0 Trace
Micrococcus luteus CM 26 67 0 0 7d
Bacillus megaterium CM 40 5 15 40 0
Bacillus subtilus CM 29 47 7 10 6e
α Data from refs. 33 and 34
β Values are in percentage of total phospholipid composition.
a OM, outer membrane.
b CM, cytoplasmic membrane.
c Phospholipid composition not different between outer and inner membrane.
d Almost exclusively phosphatidylinositol
e Including phosphatidic acid and glycolipids
f PG, Phosphatidylgylcerol
g DPG, Diphosphatidylglycerol
h L-lysl PG, Aminoacyl derivative of PG
i PE, Phosphatidylethanolamine
specific membrane composition can thus serve as a potential guide in the AMP
target specificity, such as differing Gram-positive from Gram-negative bacteria.
A lot of research has been done throughout the years on CAPs since they
first were discovered in the hemolymph of insects in the late 1970s [35]. The am-
phiphilic structure of cationic antibacterial peptides is today considered to be a
key requisite for the peptides to interact with the bacterial cell membrane [11].
In contrast to antibiotics in regular clinical use, which interact with intracellu-
lar target, the membrane-active peptides show low propensity for development
of resistance, and CAPs have therefore been heralded as new antibiotic drug
candidates targeting multiresistant pathogens. Despite all promising features of
CAPs, they have seen limited success so far. Some of the explanation for this
might be that they are quite large (∼30 residues) compared with traditionally
antibiotics and they have unresolved issues regarding toxicity and stability. The
large size of CAPs makes the production cost as well as a potential lack of sys-
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tematic applicability a big concern. It is therefore of great interest to develop
smaller CAPs in order to alleviate these concerns.
1.3 Short CAPs targeting multiresistant pathogens
Our research group has for more than a decade focused on simplifying the com-
plex AMP molecules in an attempt to bring antimicrobial peptides closer to
clinical use [36]. One important step in this direction, discovered by using
derivatives of lactoferricin, was the identification of a minimal set of structural
motifs, i.e., a pharmacophore (an ensemble of steric and electronic features that
is necessary to ensure the optimal supramolecular interactions with a specific bi-
ological target and to trigger, or block, its biological response [37]) for antibiotic
activity, consisting of two cationic charges and two hydrophobic bulk groups [38].
These small peptides (2 to 6 residues) showed substantially less hemolytic ac-
tivity and are thus more selective towards prokaryotic cells [39]. However, while
it is possible to prepare a wide array of pharmacologically active peptides, their
applicability in vivo are limited by their unfavorable properties, with regard to
administration, narrow therapeutic index, toxicity, and stability. In order to
reach an infected target, the peptide drugs can be placed either directly on the
skin, injected into the blood or taken orally. The two last options both face the
problems of digestive enzymes. Oral administration of these small CAPs is of
great interest, but is difficult because of digestive enzymes in the gastrointesti-
nal tract where peptides usually are metabolized by enzymatic cleavage of the
amide bonds joining the amino acids. Stability towards proteolytic degradation
is thus important for therapeutic peptides as a means of increasing the plasma
half life time [40].
Figure 1.3: Schematic representation of the nomenclature used for serine proteases.
The binding pockets are named S1-Sn and S1’-Sn’ where S1 is the binding site for the
peptide residue (P1) on the acyl side of the scissile bond and S1’ is the binding site for
the peptide residue (P1’) on the leaving group side of the scissile bond [41].
The proteolytic enzymes responsible for peptide degradation fall into two
general classes, the endopeptidases, which cleave the peptide sequence at more
or less specific sites, and the exopeptidases, which cleave the terminal amino
acids [42]. Proteinases, also called proteases or peptidases, describes a group
of enzymes that catalyze the hydrolysis of covalent peptidic bonds. Proteinases
form the four functional families serine, cysteine, aspartic and metallo pro-
teinases [43]. Chymotrypsin and trypsin, both members of the serine proteinase
family characterized by a nuclephillic serine residue in the active site, are key
enzymes involved in protein and peptide degradation in the gastrointestinal (GI)
18
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tract. These two endopeptidases have similar three-dimensional structure, but
different substrate specificities [44, 45] which is governed by the substrate recog-
nition sites. These include the polypeptide binding site and the binding pockets
for the peptide side chains according to the nomenclature illustrated in Figure
1.3 [41].
Figure 1.4: Orientation of the P1 Thr BPTI-bovine chymotrypsin complex around the
catalytic triad from crystal structure with PDB entry code 1t8o [46].
Chymotrypsin-like proteases are two domain structures arranged into two
six-stranded β-barrels with the active site located between these two barrels
[47]. The catalytic triad spans the active site with Ser195 on one side and His57
and Asp102 on the other side. The S1 pocket of chymotrypsin is formed by the
residues 189-192, 214-216, and 224-228 where Ser189, Gly216 and Gly226 are
considered to be the main residues that defines the substrate specificity [48, 49].
These S1 residues create a deep and hydrophobic pocket and chymotrypsin
typically cleaves C-terminally to large lipophillic amino acids, such as Trp and
Phe, where Phe as P1 is preferred over for example Ala by a factor of 5000
[50, 51]. In contrast, residue 189 of trypsin in the S1 pocket is Asp, and trypsin
consequently preferres to cleave C-terminally to cationic residues, such as Arg
and Lys [52]. In Figure 1.4 the crystal structure of the P1 Thr BPTI-bovine
chymotrypsin complex is shown illustrating the orientation of the inhibitor in
the active site[46].
When a peptide-substrate is oriented correctly in the active site it will be
cleaved between the P1 and P1’ as illustrated in Figure 1.5 where the general
serine proteinase reaction mechanism in shown. Ser195 attacks the carbonyl
of the peptide substrate assisted by His57 acting as a general base, to yield a
tetrahedral intermediate. The protonated His57 is then stabilized by a hydro-
gen bond to Asp102, whereas the oxyanion of the tetrahedral intermediate is
stabilized by interaction with the main chain NHs from Ser195 and Gly193, de-
fined as the oxyanion hole (Figure 1.4). The peptide bond is then cleaved as the
tetrahedral intermediate collapses with expulsion of the leaving group, assisted
by the protonated His57, now acting as a general acid, to yield the acyl enzyme
intermediate. In the deacylation half of the reaction water attacks the acyl en-
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Figure 1.5: Serine proteinase reaction mechanism.
zyme, assisted by His57, yielding a new tetrahedral intermediate. When this
second intermediate collapses a carboxylic acid product is expelled and Ser195
returns to the native state being hydrogen bonded to His57. It must however
be kept in mind that this is a simplification of the real reaction which involves
a network of hydrogen bonding interactions that links the substrate binding
sites to the catalytic triad. This in turn means that as the reaction proceeds,
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changes in bonding and charges at the scissile bond will propagate to more re-
mote enzyme-substrate interactions, and vice versa. Supporting evidence for
this mechanism has been taken from references [53–57].
In order to avoid proteolytic degradation of CAPs it is necessary to design
them in a way that can circumvent the reaction mechanism of these enzymes.
In recent years several strategies have been developed to improve the peptides
pharmaceutical properties. In 1999 Brinckerhoff et al. [58] reported that the
action of exopeptidases can be prevented by so-called end capping, which in-
volves chemical modification of the N- and C-terminal amino or carboxylic acid
functionalities, respectively. Inhibition of degradation by endopeptidases has
been obtained through methylation of the amide nitrogen atom or inversion of
the stereochemistry of the amino acid responsible for substrate specificity in
the enzyme [59, 60]. It has also been shown that constrained cyclic analogues
of linear peptides and incorporation of unnatural amino acids at selected po-
sitions increase the stability towards degradation and the duration of action
[61–63]. Other strategies that have been successfully employed to generate pep-
tides with both increased stability and activity involve the replacement of the
scissile amide bond bond with peptidomimetic elements or co-administration of
specific enzyme inhibitors [64, 65].
Our group has for the last ten years been developing short CAPs based on
truncated analogs of bovine lactoferricin in an effort to generate novel potent
antibiotic drugs with a low susceptibility for bacterial resistance [66]. The an-
timicrobial properties of these small cationic peptides have been increased by
including unnatural amino acids in the structures [39]. Substitution of amino
acids within a peptide sequence with unnatural analogues is thus a well estab-
lished strategy to change the peptide properties. The reported effects of such
substitutions involve reduced hemolytic activity, increased stability towards pro-
teolytic degradation, and increased potency [64, 67, 68]. To date some of the
promising CAPs are tripeptides based on arginine. In a recent report the sta-
bility towards tryptic degradation of some promising tripeptides was studied
with RP-HPLC and isothermal titration calorimetry. It was found that trypsin
was able to cleave some of the small cationic antimicrobial peptides surprisingly
well and binds them with dissociation constants ranging from 1 to 20 µM [36].
Important insight in the detailed binding mode of short peptides to trypsin was
gained in this study, and it was found that the peptides should be kept as small
as possible in order to limit interactions with as many binding sites in trypsin
as possible. It was also suggested that the amino acid occupying the P2 site
should have a side chain sterically preventing it from binding to the S2 unit
of trypsin, and that the length and the stereochemistry of the C-terminal end
capping had a major influence on the stability. Peptides with for example a
phenyl group connected via an ethyl chain to the amide nitrogen were found
to be significantly more stable than those connected via a methyl or a propyl
link [36]. The previous report presented several stable peptides towards tryptic
degradation with good antimicrobial efficacy against S. aurerus. However, while
tryptic stability is important for a potential peptidic drug, so is the stability
towards degradation by chymotrypsin, which is topic of the work presented here.
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1.4 Structure, Binding & Catalysis
In order to design new drug candidates effectively it is of utmost importance
to know the target (protein, DNA, cell membrane etc.) and the drug-target
interactions in detail. Today there are many methods available for structure
determination, and the choice of method is strongly dependent on factors such
as the molecule size, solubility and stability. The number of protein structures
in the protein data bank (PDB) [69] has been increasing fast for the last 10-15
years (Figure 1.6) with 63438 experimentally determined structures currently
deposited (February 22nd 2010). X-ray crystallography and NMR are to date
Figure 1.6: Yearly growth of total structures in the protein data bank.
the most dominant methods for structure determination, both with limitations
and advantages. NMR spectroscopy has the advantage that it can capture
motion and is thus particularly well suited for analyzing proteins that contain
extensive flexible regions or do not harbour well-defined structures. The main
disadvantage with NMR spectroscopy is the molecule size limitation (∼80 kDa).
X-ray crystallography on the other hand has no size limitations and often pro-
vides better resolution compared with NMR. The main disadvantage with X-ray
crystallography is that the molecule must crystallize, which in many cases can
be very difficult.
Binding constants and reaction rates can be experimentally determined with
techniques like equilibrium dialysis, radio-ligand binding assays, ultracentrifu-
gation, or isothermal titration calorimetry (ITC). It is also possible to determine
binding constants more indirect with spectroscopic methods. However, with in-
creasing computer power, computational chemistry is becoming an increasingly
important and reliable method for both structure prediction and interaction
studies. Computational modeling of molecules can give important insight in
molecular properties such as geometric and electronic structures, frequencies
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and relative energies. One of the main strengths with computational methods
is the opportunity to study species, processes or conditions that are difficult or
even impossible to obtain experimentally.
1.4.1 X-ray Crystallography
Solving a protein structure with X-ray crystallography requires crystals. Pro-
teins, like many molecules, can be prompted to form crystals when placed in
the appropriate conditions. Crystals are typically grown by slow, controlled
precipitation from aqueous solution under conditions that do not denaturate
the protein. As a result, individual protein molecules align themselves in a re-
peating series of unit cells by adopting a consistent orientation. This serves as
the basis for X-ray crystallography where the crystallized protein is used to de-
termine the protein’s three-dimensional structure via X-ray diffraction. There
are many substances that can potentially cause proteins to precipitate. Typi-
cally this involves the use of salts which precipitate proteins by a process called
“salting out”. However, obtaining a crystal can in many cases be extremely
difficult because there are so many variables involved such as pH, salt, organic
solvents, additives, concentration, volume, temperature and so on. Crystalliza-
tion experiments therefore involves a great deal of trial and error, and there are
no guarantees for obtaining good crystals, or crystals at all.
Crystals are formed in the two stages nucleation and growth (Figure 1.7). In
theory precipitation should occur when the combination of protein and precip-
itant concentrations exceeds a certain threshold. Ideally one would start with
conditions corresponding to the purple region of the phase diagram in Figure
1.7. Once the nuclei has formed, one would like to move into the green region,
where growth, but not additional nucleation can form [70].
Figure 1.7: a) Illustration of a phase diagram for crystallization mediated by a precip-
itant. The blue region represents concentrations of protein and precipitant at which
the solution is not saturated with protein, so neither nucleation nor growth occurs. The
green and purple regions represent unstable solutions that are supersaturated with pro-
tein. In the purple region both nucleation and growth are supported, whereas in the
green region only growth is supported. b) Illustration of an ideal strategy for growing
large crystals. First nucleation is allowed to occur under the conditions in the purple
region and secondly the condition is moved to the green region until crystal growth
ceases.
There are several techniques for crystallization, but the most popular is the
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Figure 1.8: Illustration of the hanging drop vapor diffusion method.
vapor diffusion method. Hanging drop (Figure 1.8) and sitting drop are both
vapor diffusion methods based on the same principle [70]. The main idea is
that protein, buffer and precipitant is mixed in a drop which is placed on a
glass coverslip. The reservoir solution normally contains the same as the drop,
except from the protein. Normally the precipitant concentration in the drop is
half of that in the reservoir. When the coverslip is placed on top of the well and
the system becomes closed, water from the drop will diffuse through the vapor
space and into the reservoir due to the differences in precipitant concentration
(Figure 1.8). As water leaves the drop, the protein and precipitant concentration
increase, bringing the system into the nucleation and growth region in the phase
diagram (Figure 1.7). If the conditions are ideal the system will fall back to the
growth region after being in the nucleation phase. Bad conditions either give
many tiny crystals or amorphous precipitation.
The atoms in a crystal are arranged in a regular lattice, and the spacing
between planes of atoms (referred to as Bragg planes) is comparable to the
wavelength of X-rays. Crystals can therefore diffract X-rays. In 1913 W. L.
Bragg interpreted a diffraction pattern obtained when X-rays were directed at
crystal through the well known Bragg’s law;
2dhkl sin θ = nλ (1.1)
where d is the spacing between the planes, hkl defines the plane, θ the angle
between the incident wave and the plane, λ the wavelength, and n is an inte-
ger. In order for waves to interfere constructively, the difference in travel path
must be equal to integer multipliers of the wavelength. When constructive in-
terference occurs, a diffracted beam of X-rays will leave the crystal at an angle
equal to that of the incident beam and intense reflected X-rays are produced
(Figure 1.9). There are many planes (defined as miller planes with the indices
h, k, l) within a crystal, and the crystal will consequently diffract the source
beam into many discrete beams, each which produces a distinct reflection on a
detector (usually image plate detectors or charge-coupled devices, CCD). The
intensity of the reflection from a plane hkl is dependent on the electron density
ρ(x, y, z) on that plane. This in turn is dependent on the atom types present,
and thus gives the information for potentially solving the structure. However,
the detector only measures the amplitude, which is related to the intensity, of
the diffracted wave. The phase of the wave is consequently lost in the measure-
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Figure 1.9: Bragg diffraction. When Bragg’s law is fulfilled, the diffracted X-rays from
the different planes are interfering constructively.
ment, a problem referred to as the “phase problem”. If all the phases are known,
the electron density could have been directly obtained by a Fourier transform
operation [70]. Several techniques exist for obtaining the phases, such as mul-
tiwavelength anomalous diffraction (MAD), multiple isomorphous replacement
(MIR), and single wavelength anomalous dispersion (SAD). However, with an in-
creasing number of solved protein structures available in the protein data bank,
a process called molecular replacement (MR) is often the choice of method for
obtaining the phases when doing for example ligand studies. MR makes use
of similar molecules by simulating the molecule’s packing in the crystal and
therebye obtaining theoretical phases which are to be used on the collected data
set. The method is however less desirable for solving new structures since it can
severely bias the solution of the structure. It must however be kept in mind
that crystal structures only give information about the atom coordinates, and
not the underlying complex formation.
1.4.2 Isothermal titration calorimetry
When a ligand binds to a protein, heat is either generated or absorbed. Isother-
mal titration calorimetry (ITC) is a unique thermodynamic technique for di-
rectly measuring such biomolecular interactions through the heats absorbed or
released. With an ideal adiabatic calorimeter there is no heat exchange between
the calorimeter and the surroundings, and the heat quantity Q evolved during
the experiment is thus directly proportional to the observed temperature change
∆T , and the heat capacity ε of the reaction vessel and its content [71]:
Q = ε ·∆T (1.2)
By measuring the interaction heats, the association constant (Ka), reaction sto-
ichiometry (n), and thermodynamic parameters including free energy of binding
(∆G), enthalpy (∆H) and entropy (∆S) can be determined using the relation-
ship:
∆G0 = −RT lnKa = ∆H0 − T∆S0 (1.3)
where T is the temperature in Kelvin and R the universal gas constant. Ka is
the reciprocal of the equilibrium dissociation constant Kd (Ka = 1/Kd). It is
also possible, by doing experiments at different temperatures, to determine the







Measurement of ∆Cp in addition to ∆G0, ∆H0 and ∆S0 allows a full ther-
modynamic characterization of the binding interaction, as it is this parameter
that controls the temperature variation of the other three parameters [72]. The
main advantage with ITC is thus that the enthalpy change for a biomolecular
binding interaction at a constant temperature is measured directly and without
the need of a predominated model [73].
A modern ITC instrument typically consists of two identical cells composed
of a highly efficient thermal conducting material surrounded by an adiabatic
jacket [74] (Figure 1.10). Very sensitive circuits detect the temperature dif-
Figure 1.10: Illustration of an ITC instrument. Two cells are contained within an adia-
batic jacket. A small continuous power is applied by the heater on the reference cell.
Thermopile/thermocouple detectors sense temperature differences between the refer-
ence and sample cells. On interaction of ligand and macromolecule, heat is either ab-
sorbed or generated. Depending on the nature of the association, the feedback circuit
will either increase or decrease power to the sample cell to maintain equal temperature
with the reference cell. The heat per unit time supplied to the sample cell is the observ-
able signal in an ITC experiment and a direct measure of the heat evolved on binding of
a ligand to a macromolecule. (Adapted from reference [74])
ferences between the reference cell and the sample cell as the ligand is being
stepwise injected into the calorimetric cell containing the second reagent (pro-
tein, DNA, etc.). The most sensitive instruments are able to measure interaction
heat effects of reactant concentrations as low as 1-10 nmol [71]. The heats of in-
teraction during a calorimetric titration is proportional to the fraction of bound
ligand. It is therefore extremely important to determine accurately the initial
concentrations of both the macromolecule and the ligand. It is also important
to chose appropriate concentrations of the interacting components in order to
determine Ka, ∆H, and n, which are determined by fitting the ITC isotherm to
obtain the change in free ligand concentration with respect to the total ligand
concentration. The shape of the binding isotherm is dependent on both Ka and
the concentration of the interacting components in the calorimetric cell (the
total binding site concentrations). Choosing the right concentrations is thus
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important for obtaining an isotherm that provides maximum data points for
the fitting process. This can be obtained through the relationship [75]:
C = nKa[MT ] (1.5)
where C is a unitless parameter and MT is the concentration of the macro-
molecule being titrated. A rule of thumb says that the C value should be
between 10 and 100 in to obtain maximum data points [73].










The heat released or absorbed during injection can be expressed by
q = V0∆H∆[ML] (1.8)
where q is the heat associated with the change in complex concentration ∆[ML]
and ∆H is the molar enthalpy of binding. V0 is the reaction volume of the
sample cell (Figure 1.10). As the concentration of unoccupied binding sites
begins to decrease, the heat change decrease correspondingly as more ligand is




∆[ML]i = V0∆H[ML]i (1.9)
where [ML]i is the total concentration of complex after the ith injection. How-
ever, evaluation of microcalorimetric data requires the consideration of the ob-
servable response in terms of the total ligand added or the total ligand concen-
tration [71]. The binding equations must therefore be expressed as a function
of total ligand and macromolecule concentration:
[MT ] = [ML] + [M ] (1.10)
[LT ] = [ML] + [L] (1.11)
[MT ] and [LT ] are now denoting the total macromolecule and ligand concen-
trations, whereas [M ] and [L] are the free concentrations of macromolecule and
ligand, respectively. [ML] is the concentration of the formed complex.
The model used for fitting of the obtained isotherm from an ITC experiment
depend on how many binding sites the macromolecule has. In the simplest
case each macromolecule consists of only one type of binding sites within a
finite number of identical non-interacting binding sites, all exhibiting the same
intrinsic affinity for the ligand. These models are referred to as “single set of








where Θ is the fractional saturation and [L] is the concentration of the un-
bound ligand. By mass conservation this is related to the total ligand [LT ] and
macromolecule concentration [MT ]:
[L] = [LT ]− nΘ[MT ] (1.13)




































The integral heat of reaction Q after the ith injection can now be represented
as




where V0 is the volume of the cell, ∆H is the enthalpy of binding per mole of
ligand. Similarly the differential heat of the ith injection can be represented as
qi = n[MT ]V0∆H (Θi −Θi−1) (1.17)
In order to obtain the parameters Ka, ∆H and n from a single experiment
one must do a nonlinear fit based on Eq.1.16 to the hyperbolic saturation curve
in the integral mode (Q vs. [LT ]). The same parameters can also be obtained
based on Eq.1.17 by fitting the titration data to the sigmoid saturation curve
in the differential heat mode (qi vs. [Lt], or qi vs. [LT ]/[MT ]). However, an
ITC experiment only gives the macroscopic information about the system under
investigation and is thus not appropriate for obtaining microscopic information.
1.4.3 Quantum chemistry
The Schrödinger equation
Quantum mechanics tries to describe the molecular properties based on the elec-
tron distribution. The state of a system is described by a wavefunction which
gives all possible information about the system [76]. In order to gain knowledge
about possible future states of a quantum mechanical system from its present
state, it is desirable to have an equation that describes how the wave function
changes with time and space. The Austrian physicist Erwin Schrödinger postu-
lated the well known Schrödinger equation, which in shorthand operator form
is given in Eq.1.18.
ĤΨ = EΨ (1.18)
This is the time-independent equation and is consequently known as the time-
independent Schrödinger equation. Ψ denotes the molecular wave function, Ĥ
the Hamiltonian operator, and E the total energy of the state. The Hamiltonian
operator consists of the kinetic energy operator T̂p for each particle and a po-
tential energy operator V̂pq for each distinct pair of particles. The kinetic- and
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potential energy operators are given in atomic units by the Laplace operator






























(xp − xq)2 + (yp − yq)2 + (zp − zq)2
(1.21)
Here mp are the particles’ masses and qp the charges. The dynamics of a many-
electron system is very complex, and the Schrödinger equation is only possible
to solve exactly for one- and two-particle systems. A variety of methods for
obtaining approximate solutions have therefore been developed, ranging from
semiempirical methods with adjusted parameters to highly advanced analytical
methods based on different mathematical formalisms (many-body perturbation
theory, coupled cluster, configuration interaction etc.).
Born-Oppenheimer approximation
A huge simplification to the problem of many-electron systems can be made by
realizing that the nuclei are the heaviest particles in a molecule. The lightest
nucleus is the proton, 1H, which is ≈ 1836 times as heavy as an electron, while
the most abundant carbon nucleus, 12C, is ≈ 21863 times as heavy. This means
that the electrons and the nuclei will act differently according to molecular
motion. When the nuclei change their configuration slightly the electrons will
immediately adjust. If one assume that the Hamiltonian is separable into two
or more terms, then the total eigenfunctions are products of the individual
eigenfunctions of the separated Hamiltonian terms, and the total eigenvalues are
sums of individual eigenvalues of the separated Hamiltonian terms. For example,
if ψ(q1, q2) can be written as ψ(q1)ψ(q2) and the Hamiltonian separable into two
terms Ĥ = Ĥ1(q1) + Ĥ2(q2). Assuming that the wavefunction can be written in
this way and that ψ(q1) and ψ(q2) are eigenfunctions of Ĥ1 and Ĥ2 then
Ĥψ(q1, q2) = (Ĥ1 + Ĥ2)ψ(q1)ψ(q2)
= Ĥ1ψ(q1)ψ(q2) + Ĥ2ψ(q1)ψ(q2)
= E1ψ(q1)ψ(q2) + E2ψ(q1)ψ(q2)
= (E1 + E2)ψ(q1)ψ(q2)
= Eψ(q1, q2) (1.22)
Thus the eigenfunctions of Ĥ are products of the eigenfunctions of Ĥ1 and Ĥ2,
and the eigenvalues are the sums of eigenvalues of Ĥ1 and Ĥ2. This allows for
an approximation where the nuclei and electronic wavefunctions are separated,
a result known as the Born-Oppenheimer approximation [77]. First the nu-
clear kinetic energy operators T̂n are separated from the electronic Hamiltonian
Ĥel, which then consists of zero-electron, 1-electron and 2-electron parts (n,m
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V̂ef = ĝ (1.26)
The electronic Schrödinger equation is then solved for all electronic states (k)
where the nuclear coordinates rn enter hnuc and ĥ as parameters:




k (re; rn), k = 0, 1, 2...∞ (1.27)
The solutions from the electronic Schrödinger equation, Eelk , are called the po-
tential energy surface (PES). The equilibrium geometry is defined as the con-
figuration of rn that gives the lowest energy on the groundstate PES (Figure
1.11). In the second step, the complete Schrödinger equation is solved with an
Figure 1.11: Illustration of the potential energy surface from the electronic Schrödinger
equation in one dimension.






k (re; rn), Ĥ
totψtot = Etotψtot (1.28)
where the ψnuck are the coefficients and the ψ
el
k the basis of the expansion. This
finally leads to an infinite set of coupled Schrödinger equations given as:(∑
n
T̂n + Eelk (rn)
)
ψnuck (rn) = E
totψnuck (rn) (1.29)
In practice, the Born-Oppenheimer approximation implies that the electronic
wavefunction can be solved in a stationary nuclear framework. Equation 1.29 is
however no less complicated than the original Schrödinger equation, but it can
be truncated to a good approximation, both in the number of PESs included,




The eigenfunctions of the electronic Schrödinger equation can for a single-
electron system properly be called molecular orbitals. If the system only has one
nucleus, the equation can thus be solved exactly, and the eigenfunctions would
be hydrogen-like atomic orbitals. It is thus possible to use these orbitals as a
starting point for constructing more complicated molecular orbitals through an
approach called the “linear combination of atomic orbitals” (LCAO) [78]. First






where the set of N functions φi comprise the basis set and each φi is associated
with some coefficient ai. The variational principle states that an approximate





The “bra-ket” 〈...|...〉 is a short hand notation for integrals over all coordinates
where the “bra” 〈...| is complex conjugated and the denominator ensures that
the wavefunction is normalized. The energy is only equal if the wavefunction
is exact, providing a powerful tool for solving the wavefunction. As long as the
energy keeps dropping, one is on the right track.
In the self-consistent field (SCF) approximation the problem of solving the
N-electron Schrödinger equation is tackled by writing the wavefunction as a
slater determinant. The slater determinant is an anti-symmetrized product of
N orthonormal orbitals φ1, φ2...φN which are 1-electron wavefunctions:




φ1(r1) φ2(r1) · · · φN (r1)





φ1(rN ) φ2(rN ) · · · φN (rN )
∣∣∣∣∣∣∣∣∣ (1.32)
The slater determinant ensures that the wavefunction switches sign when two
electrons are interchanged, as required by the Pauli principle. The factor 1/
√
N
ensures that ψ is normalized. By applying the variational principle to the slater
determinant, one obtains the Hartree-Fock model [79]. The energy may then be
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where the factor of 1/2 allows the double sum to run over all electrons. hi
describes the motion of electron i in the field of all the nuclei. Jij is the Coulomb
integral, Kij is called the exchange integral, and Vnn is the nuclear potential
energy. The SCF class of models have in common that they attempt to solve
an N-electron Schrödinger equation by solving coupled 1-electron Schrödinger
equations. The term “self-consistent” is derived from the coupling between the
1-electron Hamiltonian, called the Fock operator and the solutions (orbitals).
The Fock operator in these terms become:




where the Jj and Kj operators are defined as
Ji|φj(2)〉 = 〈φi(1)|g12|φi(1)|φj(2)〉 (1.39)
Ki|φj(2)〉 = 〈φi(1)|g12|φj(1)|φi(2)〉 (1.40)
and gij is a two-electron operator giving the electron-electron repulsion
gij =
1
|ri − rj |
(1.41)
The Fock operator is thus an effective one-electron operator which describes
the kinetic energy of an electron and the attraction to all the nuclei hi, as well
as the repulsion to all the other electrons. The variation of the energy is then





where the Fock operator is associated with the variation of the total energy and







λij (〈δφi|φj〉+ 〈φi|φj〉) (1.43)
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The desired orbitals are those that make δL = 0. The Lagrange multipliers [80]
are however elements of a Hermitian matrix (λij = λ∗ij). Therefore the final set





The equation can again be simplified by choosing a unitary transformation (the
total wave function is unchanged by a unitary transformation of the occupied
MOs among themselves, because changing rows and columns in a determinant is
not affecting the determinant itself) that makes the matrix of Lagrange multipli-
ers diagonal (i.e λij = 0 and λii = εi). This special set of molecular orbitals (φ′)







The Lagrange multipliers are the expectation value of the Fock operator in the
MO basis
〈φ′i|Fi|φ′i〉 = ε〈φ′i|φ′i〉 = εi (1.46)
The Hartree-Fock equations form a set of pseudo-eigenvalue equations as the
Fock operator depends on all the occupied MOs. A specific Fock orbital can only
be determined if all the other occupied orbitals are known. Iterative methods
must therefore be employed for solving the problem. A set of functions that is a
solution to Fiφ′i = εiφ
′
i are called self-consistent field orbitals. The total energy









(Jij −Kij) + Vnn (1.47)
where




Since the Fock operator contains terms describing the repulsion to all other
electrons (J and K), and the sum over MO energies it therefore counts the
electron-electron repulsion twice, which must be corrected for. Moreover, the
energy can not be exact as it only accounts for the repulsion in an average
fashion. This is due to the approximation of a single Slater determinant of
N spin orbitals as a trial wave function and the HF method is therefore often
referred to as the mean-field approximation.
The SCF method (HF) is the simplest wavefunction-based method, but since
each particle is assumed to experience a mean field created by the other particles
the total energy can not be 100% correct. If one use a complete set of orbitals,
the solution of the Schrödinger equation would yield the exact single determinant
representation, and representing the wavefunction as an expansion in a complete
basis of determinants would yield the exact solution of the wavefunction within
the Born-Oppenheimer approximation. This is a powerful concept, because
increasing the number of basis functions generally would improve the accuracy of
the models, and this generally holds well for molecular modeling. In a sufficient
large basis set the HF wave function ΦHF is thus able to account for ∼99% of
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the total energy. The remaining 1% on the other hand can often be of great
importance for describing chemical phenomena. The difference between the HF
energy and the lowest possible energy in a given basis is called the electron
correlation (EC) energy, which correspond to the motion of the electrons being
correlated. In order to improve on the HF results the trial wave function must
contain more than one Slater determinant. Typically this is done by using the
HF wave function as a starting point for improvements (because the HF method
determines the energetically best one-determinant trial wave function within a
given basis set), creating a generic multi-determinant trial wave function as




where a0 is usually close to one. The main methods for calculating the electron
correlation by using multi-determinant trial wave functions (Eq.1.49) are many-
body perturbation theory (MBPT), configurational interaction (CI) and coupled
cluster (CC).
Kohn-Sham Density Functional Theory
The original idea behind density functional theory was to have an orbital-free
expression for the energy of the electron in terms of the electronic probability
density ρ. The main flaw with this concept was the poor representation of the
kinetic energy and thus not a significant improvement compared with wave me-
chanics. The success of modern DFT was the introduction of orbitals by Kohn
and Sham. They made DFT available for computational chemistry by intro-
ducing the concept of a non-interacting reference system built on one-electron
functions [81]. Even though the electrons are interacting, the difference between
the exact kinetic energy and that calculated assuming non-interacting orbitals
is small, and like the HF theory it provides ∼99% of the correct energy. The
remaining kinetic energy is absorbed into an exchange-correlation term EXC [ρ].
The Kohn-Sham model is thus closely related to the HF method, sharing iden-
tical formulas for the kinetic electron-nuclear and Coulomb electron-electron
energies. A general DFT energy expression can be written as























The subscript S denotes that the exact kinetic energy of the non-interacting
system is calculated from a slater determinant and ρ(r) denotes the total elec-
tron density at a particular point r in space. Ene[ρ] is the attraction between
electrons and nuclei and J [ρ] the Coulomb energy. The kinetic energy of the
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non-interacting reference system TS , the attraction between electrons and nuclei
and the Coulombic repulsion between electrons are thus calculated exactly in
the Kohn-Sham approach. The problem is that the Hohenberg-Kohn theorems
do not state the relationship between the functional and the density [82]. The
challenge in DFT for a given density is to design a functional that models EXC
well. The definition of EXC can be obtained by equating EDFT to
EXC [ρ] = (T [ρ]− TS [ρ])︸ ︷︷ ︸
A
+ (Eee[ρ]− J [ρ])︸ ︷︷ ︸
B
(1.54)
where A may be considered as the kinetic correlation energy, while B contains
both potential correlation and exchange energy. It is also a usual approach to
handle the exchange part and the correlation part separately (EXC = EX+EC).
The model functionals in use may be classified into five different subgroups;
the local (spin) density approximation (L(S)DA), the generalized gradient ap-
proximation (GGA), meta-GGA, hybrid (or hyper-GGA) functionals, and gen-
eralized random phase (GRP) methods. These methods differ in the way they
approximate the EXC part in Eq.1.50. In the LDA methods, the approximated
value of the exchange-correlation term at position r is computed exclusively
from the local density ρ(r), and typically the density is treated as a uniform
electron gas. In the GGA methods, the gradient of the electron density is also
taken into account, to adjust for the general non-uniform electron density case.
The hybrid functionals are named so because a part of the exchange contribu-
tion is taken from a Hartree-Fock method calculation and parameterized into
the functional. Hybrid functionals have seen great success, and one of the most
popular methods is the B3LYP [83]:
EB3LY PXC = (1−a)ELSDAx +aEexactx +b∆EB88x +(1−c)ELSDAx +cELY Pc (1.55)
The a, b and c parameters are determined by fitting to experimental data. Table
1.3 shows an overview of commonly used functionals given by their acronym,
and placed in the Jacob’s ladder classification[76].
Table 1.3: Perdew classification of exchange-correlation functionals (adapted from
ref.[76]).
Level Name Variables Examples
1 Local Density ρ LDS, LSDA, Xα
2 GGA ρ, ∇ρ BLYP, OPTX, OLYP, PW86
3 Meta-GGA ρ, ∇ρ, ∇2ρ or τ BR, B95, PKZB, TPSS
4 Hyper-GGA ρ, ∇ρ, ∇2ρ or τ H+H, B3LYP, O3LYP
HF exchange
5 Generalized RPA ρ, ∇ρ, ∇2ρ or τ OEP2
HF exchange
Virtual orbitals
One of the greatest advantages of DFT compared to ab initio (wavefunction
methods) calculations is the low computational cost, especially for larger sys-
tems. The main disadvantage with DFT is that it is not possible to carry out
systematic improvement by taking more electron configurations into account as
35
1. INTRODUCTION
in wavefunction methods. The only way to improve the results is to use better
functionals. However, even though the computational cost is lower compared
with wavefunction methods, it is still not possible, in terms of computational
cost, to model large systems like proteins, molecules in explicit water or mem-
brane systems with DFT. In order to model larger systems it is desirable to
use the less complicated molecular mechanics (MM) methods that ignore the
motion of the electrons.
1.4.4 Molecular Mechanics and Force Fields
Without the assumption of the Born-Oppenheimer approximation it would not
be possible to write the energy as a function of the nuclear coordinates, so this
is one of the strongest and most important assumptions that makes molecu-
lar mechanics work. Molecular mechanics is further on based on more or less
simple models of the interactions within a system. Typically the contributions
come from processes such as bond stretching, rotation about single bonds, the
opening and closing of angles, torsional terms and non-bonded interactions. In
principle all force fields contain at least the five terms for describing bonds,
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where Vpot(rN ) denotes the potential energy, which is a function of the positions
(r) of N particles (usually atoms). Transferability is also an important concept
of force fields as it enables a set of parameters developed and tested on a rela-
tively small number of cases to be applied to a much wider range of problems.
Transfarebility means that the same set of parameters can be used to model a
series of related molecules, rather than having to define a new set of parameters
for each individual molecule. Another point is that parameters developed from
data on small molecules can be used to study much larger molecules.
When defining a force field one must not only specify the functional form
but also the parameters to be used. In other words, two force fields may use the
same functional form but different parameters, and force fields with different
functional forms may give results of comparable accuracy [84]. A specific force
field is further on designed to predict certain properties and will therefore be
parameterized accordingly. Trying to predict other properties than the specific
force field is designed for is in general not a good idea. Another important point
to keep in mind is that force fields are empirical. There are in other words no
“correct” form for a force field. One could claim that the principle of “survival
of the fittest” applies to force fields as well. If one functional form is shown to




In molecular mechanics calculations it is rare that the bonds involved deviate
significantly from their equilibrium values. It is therefore common to use the
simple approach of the Hook’s formula in which the energy varies with the




(r − r0)2 (1.57)
A true bond-stretching potential is not harmonic, but has a shape typically
given by the Morse potential which resembles the dissociation limit in a better
fashion:




µ is the reduced mass and De is the depth of the potential energy minimum.
Even though the Morse potential resembles the true energy curve in a better
fashion than Hook’s law, it is rarely used in molecular mechanics. This is
mainly because it requires three parameters to be specified for each bond and
the formula itself is not particularly amenable to efficient computation. Hook’s
law can thus be used to model the Morse potential more accurate by doing a






1− k′(r − r0)− k′′(r − r0)2 − k′′′(r − r0)3 − · · ·
]
(1.59)
The MM2 [85] force field for example includes just the quadratic and cubic
terms. Far from the reference value the cubic function passes through a maxi-
mum, which in turn can lead to catastrophic lengthening of bonds. Inclusion of
the quartic term, as in MM3 [86], eliminates this inversion problem and leads
to a better description of the Morse curve.
Angle Bending
The same arguments used for bond stretching is also applied for angle bending




(θ − θ0)2 (1.60)
As with bond-stretching terms, the accuracy of the force field can be improved






1− k′(θ − θ0)− k′′(θ − θ0)2 − k′′′(θ − θ0)3 − · · ·
]
(1.61)
In general much less energy is required to distort an angle away from the equi-
librium than to stretch a bond. Consequently, the force constants are propor-




The conformation of molecules are in general largely determined by torsional
terms and non-bonded interactions. This is because angle bending and bond-
stretching requires substantial energies to change from their initial values. Gen-
erally little energy is required to change the torsional terms, and this “softness”
in turn leads to large variations. Moreover, the existence of barriers to rotation
about chemical bonds is fundamental to understanding the structural properties
of molecules and conformational analysis. Most force fields for organic molecules
use explicit torsional potentials with contributions from each bonded quartet of
atoms A-B-C-D. Ethane for example would thus involve nine individual torsional







[1 + cos(nω − γ)] (1.62)
Vn is often referred to as the barrier height, ω the torsional angle, γ, the phase
factor, which determines where the torsion angle passes through its minimum
value, and n is the multiplicity determining the number of minimum points in
the function as the bond is rotated 360o. Ethane for example with a double
bond between the two sp2 carbon atoms would thus have n = 2 and γ = 180o,
giving minima at 0o and 180o. The value of Vn would also be larger for ethane
compared with ethane for example.
Improper torsions
Many chemical systems are planar, and this planarity is taken care of by using
either improper torsions or out-of-plane bending terms. In other words, in order
to achieve the wanted geometry for planar systems it is necessary to incorporate
additional terms in the force field that keeps the sp2 carbon in the same plane as
the three atoms bonded to it. Per definition improper atoms are between four
atoms that are not bonded in the sequence 1-2-3-4. An example of a torsional
potential used to maintain the improper torsion angle at 0o or 180o is given as:
v(ω) = k(1− cos(2ω) (1.63)
Improper torsions can also be used to keep things at a certain degree out-of-








θ is here the angle between the out-of-plane atom and the plane, and h in the
second equation is the distance from the plain to the out-of-plane atom. It
is however important to remember that out-of-plane terms may not always be
necessary, and that to include such terms may have a deleterious effect on the
performance of the force field [84].
Cross-terms
In theory cross terms between all possible contributions to a force field should
be included due to coupling between the internal coordinates. For example, as a
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bond angle is decreased it is found that the adjacent bonds stretch to reduce the
interaction between the atoms that comes closer due to the decrease of the angle.
It has however been found that only a few cross terms are generally necessary
in order to reproduce structural properties accurately. A few important terms
are bond-bond, bond-angle, angle-angle, bond-torsion and angle-torsion. The





[(r1 − r1,0)(r2 − r2,0)] (1.65)
Even though not all cross terms are included in a force field one must remember
that all the terms in reality are connected.
Non-bonded interactions
Non-bonded interactions are usually modeled using van der Waals and electro-
static interactions. The charge distribution can be represented in many ways,
but one common approach being an arrangement of fractional point charges
throughout the molecule. These charges are thus designed to reproduce the
electrostatic properties of the molecules. Typically the electrostatics between
two molecules or between different parts of the same molecule is calculated as









This expression correspond to monopoles which are important terms to include.
Dipoles, octapoles, etc., goes extremely fast towards zero and can normally be
neglected. The charge-charge energy thus decays as ∼ r−1 while the dipole-
dipole energy decays as ∼ r−3 which is much faster. The electrostatic inter-
actions are very important in terms of polarizability because charges move in
response to other charges. The polarization effect is of crucial importance when
simulating a molecule in water or when predicting ligand binding.
The van der Waals effects are in general small, but for larger systems, like
proteins, they become non-negligible when summing them up. The most im-
portant interactions within van der Waals arises from induced dipole-dipole
interactions between molecules that do not have a permanent dipole. Typically
the attraction is calculated as being ∝ r−6 while the repulsion due to electron
cloud overlap is calculated as being ∝ r−12. The best known of the van der










ε is the well depth and σ is the collision diameter, both being adjustable pa-
rameters. For polyatomic systems it is usual to calculate the van der Waals
interaction energy between two molecules using a site model in which the inter-
action is determined as a sum of the interactions between all pairs of sites on
the two molecules. The determination of van der Waals parameters can further
on be difficult and time consuming process for larger systems. It is therefore
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common to assume that the parameters for the cross interactions can be ob-
tained from the parameters of the pure atoms using so called mixing rules. The








This formulation is most successfull when applied to similar species. The OPLS
force field developed by Jorgensen and Tirado-Reeves in 1988[87] on the other
hand calculates the collision diameter for mixed interactions as the geometric
mean of the values for the two component atoms, which has seen great success.
1.4.5 Molecular Dynamics
Molecular dynamics (MD) is a computer simulation method in which atoms and
molecules are allowed to interact for a period of time by the approximations of
known physics. MD simulation is a commonly used method for studying the
time dependent interactions of proteins and biomolecules. The analysis of a
potential energy surface by locating the minima and saddle points corresponds
to modelling the system at 0 Kelvin. Inclusion of a finite temperature can be
done by means of statistical mechanics methods. In a molecular dynamics sim-
ulation, the macroscopic quantities derived from the partition function must be
estimated from a representative sampling of the phase space. The word simula-
tion in turn refers to methods aimed at generating a representative sampling of a
system at a finite temperature. There are mainly two techniques for generating
an ensemble, Monte Carlo (MC) and molecular dynamics (MD).
The successive configurations of the system in molecular dynamics are gener-
ated by integrating Newton’s laws of motion. The resulting trajectory describes
how the positions and velocities of the particles in the system vary with time.
The trajectory in turn can be obtained by solving the differential equations







mi is the particle mass, xi is the direction in which the particle is moving, and
Fxi is the force acting on the particle in the direction of xi.
In the early days of MD simulations the hard-sphere model was used for the
simulations. In such cases each particle is a sphere that moves at constant veloc-
ity in straight lines between collisions, where all collisions are perfectly elastic
and occurs when the separation between the centres of the spheres equals the
sphere diameter. After collision, the new velocities are calculated by applying
the principle of conservation of linear momentum. The steps involved in the
hard-sphere calculations are:
1. Identify the next pair of spheres to collide and calculate when the collision
will occur.
2. Calculate the positions of all the spheres at the collision time.
3. Determine the new velocities of the two colliding spheres after collision.
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4. Repeat from 1 until finished.
The simple model of hard-spheres suffer from many deficiencies, but has proven
usefull to gain usefull insight into the microscopic nature of fluids.
Molecular Dynamics with continuous potentials
In a realistic model of intermolecular interactions, the force acting on each
particle will change whenever the particle changes its position. However, under
the influence of a continuous potential the motions of all particles are coupled
together, which in turn gives rise to a many-body problem that can not be
solved analytically. A solution to such problems is to integrate the equations of
motion using a finite difference method.
The finite difference technique is used to generate molecular dynamics tra-
jectories with continuous potential models, which is assumed to be pairwise
additive. The idea is that the integration is broken down into many small steps,
each separated in time by a fixed time δt. The total force on each particle in the
configuration at time t is calculated as the vector sum of its interactions with
the other particles. From this force, the accelerations of the particles can be
determined, which in turn are combined with the positions and velocities at a
time t to calculate the new positions and velocities at time t+δt. An important
point here is that the force is assumed to be constant during the time step.
Therefore small time steps are important. Many algorithms for integrating the
equations of motion using finite difference methods have been developed, but
all assume that the positions and dynamic properties can be approximated as
Taylor series expansions:






δt3b(t) + · · · (1.71)
v(t+ δt) = v(t) + δta(t) +
1
2
δt2b(t) + · · · (1.72)
a(t+ δt) = a(t) + δtb(t) + · · · (1.73)
· · · = · · ·
v is here the velocity, a the acceleration, b the third derivative or the position
with respect to time, and so on. There are many algorithms which uses different
variants of this scheme. Some of the most common are the Verlet algorithm [88]
and variants of the verlet algorithm.
The most demanding part of a molecular dynamics simulation is invariably
the calculation of the force on each particle in the system. The integration algo-
rithm used should obey some requirement where some important considerations
are that the integration algorithm should conserve energy and momentum, be
time-reversible, and it should permit a long time step to be used. A long time
step will in computational terms require fewer iterations to cover a given amount
of phase space.
Another important method is the predictor-corrector methods [89]. These
methods have three basic steps:
1. New postions, velocities, accelerations and higher-order terms are pre-
dicted according to the Taylor expansions to order c in Eq.1.71.
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2. The forces are in the second stage evaluated at the new positions to give
accelerations a(t+ δt).
3. The accelerations obtained from stage 2 are then compared with the pre-
dicted ones from stage 1. The difference between these to is then used to
“correct” the positions, velocities, etc., in the correction step:
∆a(t+ δt) = ac(t+ δt)− a(t+ δt) (1.74)
From this it follows that:
rc(t+ δt) = r(t+ δt) + c0∆a(t+ δt) (1.75)




a(t+ δt) + c2∆a(t+ δt) (1.77)
· · · = · · ·
The values of the coefficients ci can vary from one algorithm to the other, but
Gear suggested that the coefficients should depend on the order of the Taylor
expansion [89].
Choosing time steps
Choosing the right time step for a molecular dynamics simulation is of crucial
importance for obtaining well-behaved trajectories. It has been shown that
for short time steps the predictor-corrector methods may be more accurate,
while for longer time steps the Verlet algorithm may be better [90]. If the time
step chosen is too small, the trajectory will cover only a limited proportion
of the phase space. If the time step is too large, instabilities may arise in
the integration algorithm due to high energy overlaps, and the calculation may
“blow up”. The aim is thus to find the correct balance between simulating the
“correct” trajectory and covering the phase space. A typical rule of thumb to
follow for MD simulations is that the time step should be approximately one
order of magnitude smaller than the shortest motion of vibration. A C-H bond
for example vibrates with a repeat period of approximately 10 fs. A suitable
time step for system with C-H vibrations would then be 1 fs.
The restriction of the time step being dictated by the highest frequency mo-
tion present in the system is clearly a severe restriction, particularly since many
of the high-frequency motions usually are of little interest as they have minimal
effects on the overall system. One solution to this problem is to “freeze out”
such vibrations by constraining the appropriate bonds to their equilibrium while
still permitting the rest of the degrees of freedom to vary under the intramolec-
ular and intermolecular forces present. This in turn enables longer time steps
to be used and consequently larger parts of phase space to be covered.
The most common method for applying constraints in molecular dynamics is
the so called SHAKE procedure proposed by Ryckaert, Ciccotti and Berendsen
in 1977 [91]. The SHAKE constraint removes the bond stretching degrees of
freedom in the force field. This is an iterative method where the constraints are
treated one by one, and the coordinates are adjusted to satisfy each constraint
in turn until all are within a specific tolerance. After the correction has been
applied to all bonds in turn, every bond is checked. If there are any large
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deviation, the process starts over. The process will be repeated until all are
converged. The forces for the constrained bonds do not need to be computed
when using this method. The equilibrium bond lengths are however needed
since SHAKE uses them to reset the atomic postions. A rule of thumb says
that if one can constrain all the C-H bonds, the time step can be doubled. A
last note of warning, if SHAKE fails there is usually something wrong with the
system and not related to problems with SHAKE.
Molecular dynamics can not be used to generate initial coordinates for the
atomic positions, so this needs to be obtained somehow before starting a simula-
tion. This can be done in several ways depending on what system one is working
with. When studying ligand-protein interactions, the initial coordinates for for
the protein atoms can be obtained obtained from experimental crystal struc-
tures. Starting coordinates for a protein-ligand complex can then be obtained
from for example molecular docking experiments.
1.4.6 Molecular Docking
Molecular docking is an example of the global optimization problem where the
goal is to determine the best alignment of two molecules with respect to each
other. Molecular docking refers to the case where one tries to fit a small molecule
into a large target structure. When docking a ligand into the active site of a
rigid enzyme, one is dealing with a problem consisting of six degrees of free-
dom, three translational and three rotational, besides those arising from the
ligand confirmations. The idea is that the three translational degrees of free-
dom can be sampled on a grid by for example placing the ligand center of mass
within a central box with grid points every 1 Å. A small box of for example
10× 10× 10 Å thus generates ∼ 1000 possible points. At each point the overall
rotational orientation of the ligand must be sampled, thereby typically gener-
ating a few hundred possibilities. A specific set of intermolecular translational
and rotational variables is called a pose, and it is clear that there will be ex-
tremely many of them. Molecular docking is consequently a demanding task
even though the majority of the poses can be rejected based on for example
atom pair distances between the ligand and the receptor. Global optimization
schemes such as genetic algorithms are therefore often employed for solving the
optimization problem [84].
Using standard force fields which attempts to calculate the enthalpic inter-
actions and an estimate of the free energy by simulation methods in molecular
docking is far too expensive in terms of computational cost. The idea of force
fields developed for molecular docking is that the non-bonded part of a force
field function can be augmented with empirical terms and therebye hopefully
capturing some of the entropy and solvent effects. The resulting scoring function
can further on be parameterized against experimental binding data. A scoring
function typically contains terms like [92]:
∆Gscore = a1∆EvdW +a2∆Eel+a3∆Grot+a4∆GH−bond+a5∆Gsolv · · · (1.78)
where EvdW are the van der Waals contribution to the interaction energies, Eel
the Coulombic contribution, Grot the energy of rotation, GH−bond the energy
based on hydrogen bond donors and acceptors and Gsolv the energy required
to displace water molecules when a ligand binds to a receptor. The ai are
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weighting factors that can be fitted to actual binding data for specific protein-
ligand systems.
To date there more than 60 docking programs and more than 30 scoring
functions have been disclosed [93]. Some of the most widely used programs
include AutoDock [94], DOCK [95], GOLD [96], Glide [97] and FlexX [98].
The different programmes generally differ in the method used to explore the
conformational space of the ligand and/or the protein target, and the scoring
function used to evaluate the proposed binding mode (the pose). In theory the
scoring function should guide the conformational sampling algorithm and thus
assign the best score to the “correct pose” (the native pose observed in crystal
structures). Whenever choosing a docking program, two inversely correlated
factors are to be considered. First of all speed is essential for effective virtual
high-throughput screening of large libraries, and secondly the accuracy is critical
for lead optimization.
Some of the search algorithms used for conformational sampling include the
genetic algorithm (GA), differential algorithm (DE), rigid-body docking (RBD),
simulated annealing (SA), monte carlo (MC) and molecular dynamics (MD)
[84]. MC and GA algorithms are examples of stochastic methods that explore
the ligand conformational space on the fly. With MC, which is used in for
example Glide, the pose of the ligand is sequentially modified through bond
rotation, translation and/or rigid body rotation, one or more parameters at a
time, and the new conformation is then evaluated. The new conformation is kept
if it is lower in energy than the previous, else it is rejected or evaluated using a
selection criterion such as the Metropolis criterion. This allows for higher energy
conformation to exist by allowing a temperature dependence, resulting in the
crossing of energy barriers on the potential energy surface. Generally the higher
the temperature, the more likely it is that a higher energy conformation is kept
[93]. The scoring functions on the other hand attempt to predict the binding
free energy or to rank-order compound by their bioactivity. These functions are
classified as empirical, force field (FF) based, and knowledge based [99–103].
Some of the most successfull scoring functions belong to the empirical class
where the energetics of the ligand binding is decomposed into simpler, scalable
contributions arising from, for example, metal ligation, hydrogen bonds, freezing
of rotatable bonds and hydrophobic effects (Eq.1.79).










f(∆r) + ∆GrotN ′rot
The various scaling factors (∆Gi) in Eq.1.79 are defined by regression to fit
experimentally determined protein-ligand affinities. Some well known examples
of such scoring functions include ChemScore[104] (implemented in GOLD among
others), GlideScore[105, 106] (implemented in Glide) and AutoDock SF[107]
(implemented in AutoDock).
Due to the high computational costs of docking, the receptor is normally
treated as a rigid body. This means that the bond angles, torsion angles and
bond lengths of the protein residues are not modified at any stage of the complex
generation. In some cases conformational changes can be very important during
the complex formation, and rigid-body docking is thus inadequate for dealing
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with such problems. Alternatively one can use a method that scores possible
conformational changes, called flexible docking. However, scoring all possible
conformational changes for the whole receptor is still too expensive with respect
to computer time, and one must thus select small subsets of possible conforma-
tional changes to be considered. It has previously been pointed out based on
statistical analysis of the protein databank that ∼85% of the structures contain
one to three flexible residues [108]. Small adjustment of the protein can thus
have a significant effect on the molecular recognition process, and this is one of
the major challenges within the development of new docking algorithms. Many
approaches for dealing with protein flexibility have been proposed and recently
reviewed by Cavasotto et al. [109]. However, very few of these algorithms have





1.5 Aims of study
The main goal of this project is to identify tripeptides with antimicrobial activity
that have high stability towards chymotryptic degradation and that potentially
can serve as a lead for an oral drug. The mode of action for these tripeptides
is further on not known, and it is therefore also a goal to identify a possible
mechanism for the peptide membrane interaction. This knowledge is of great
interest as it hopefully will enable us to design better and more specific antimi-
crobial peptides. As a step in the direction towards these goals, computational
and experimental methods are going to be combined on a set of tripeptides
with different unnaturally occurring side chains. The work is divided into the
following parts:
1. Investigate the three dimensional structure of the tripeptides in solvent
with computational methods for closer investigation of properties and be-
havior.
2. Perform molecular dynamics simulations of tripeptides in a membrane
environment in order to propose a possible mode of interaction with a
bacterial cell membrane.
3. Investigate the potential tripeptide binding mode and possibility for sta-
bility towards chymotryptic degradation with molecular modeling.
4. Perform isothermal titration calorimetry (ITC) studies to determine ther-
modynamic properties and verifying the computational modeling results.
5. Obtain a crystal structure of the peptide-enzyme complex for experimental
determination of the binding mode and to verify the modeling results.
The tripeptides in this project are based on RWR-NHBn (Figure 1.12) which
contain three cationic charges and two hydrophobic elements and displays a
medium antibacterial activity [110]. The goal is to investigate the effect towards
chymotryptic degradation of varying the different amino acids X and Y, and type
of modification to the C-terminal (Z), as illustrated in Figure 1.12.
Figure 1.12: General scaffold of the peptides included in the study of RWR-NHBn and
the variables X, Y and Z.
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“Anyone who has never made a mistake has never tried anything new“.
−Albert Einstein
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2. Material & methods
Standard chemicals used in solutions were purchased from Sigma, AppliChem
and Merck. α-chymotrypsin was purchased from Wartington and Sigma. All
tripeptides used in this project were synthesized as described by Svenson et al.
[111]. Molecular figures used for illustrations were generated using PyMol [112].
2.1 Peptide models
Molecular models of all tripeptides (Table 2.1 and Figure 2.1) were built with
Maestro version 9.0 [113]. The geometries were first relaxed with the univer-
sal force field (UFF) minimiser in Maestro to eliminate distortions. Peptide
geometries were further minimized with MacroModel version 9.6 [114] to pre-
pare the peptides for the docking experiment. The OPLS2005 [115] force field
was selected for all optimizations with the Polak-Ribiere-type conjugate gradient
(PRCG) minimization scheme[116] and continuum solvent (water). Long-range






















2. MATERIAL & METHODS
Figure 2.1: Illustration of residues and naming convention for the tripeptides.
interactions were treated with the extended cutoff method with truncation of
the potentials after 4 Å, 8 Å and 20 Å for H-bonds, van der Waals and elec-
trostatic interactions, respectively. The minimization was considered converged
based on the gradient using a convergence threshold of 0.05. The minimized
tripeptides were then prepared for the docking experiments with LigPrep [117]
using the OPLS2005 force field. LigPrep was set to generate possible states at
target pH between 4.0 and 8.0, at most 32 per ligand.
2.2 Electronic geometry optimization
Geometry optimizations of peptides were performed using density functional
theory (DFT) with Gaussian03 [118] and Jaguar version 7.5 [119]. Gaussian03
and Jaguar offer different solvent models, and both were chosen to see if there
were any difference in the performance of the programs and the solvent models.
Calculations were run with the B3LYP [83, 120–122] and the M05-2X [123]
functionals using the Pople basis set 6-31G(d,p) [124–133]. The charge of the
molecules were set to 3 and the spin multiplicity to 1.
Calculations with Gaussian03 were performed with the self-consistent field
(SCF) procedure which uses a combination of convergence schemes EDIIS [134]
and CDIIS with no damping or Fermi broadening. The optimization was done
in the presence of solvent (water) by placing the solute in a cavity within the
solvent reaction field. The Polarizable Continuum Model (PCM) using the
integral equation formalism variant (IEFPCM) was selected by including the
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keyword SCRF=IEFPCM. Calculations with Jaguar were performed with the
implemented PBF solvation model [119] and the DIIS [135] convergence scheme.
The convergence criteria was specified with an energy change set to 5 · 10−5
Hartree and a RMS density matrix change set to 5 · 10−6. Thermochemistry
was set to 1.00 atm pressure and a start temperature of 298.15 K.
2.3 Molecular Dynamics
2.3.1 Solvent simulation
All molecular dynamics simulations of peptides in solvent were carried out us-
ing the MD program package Q [136] developed by Åqvist and co-workers. The
Q software is build up from the four programs Qprep, Qdyn, Qfep and Qcalc.
These programs are used in three steps necessary for doing molecular dynamics
simulation with Q, a preparation stage, a calculation stage and an analyzing
stage, as illustrated in Figure 2.2. Before starting a molecular dynamics simula-
Figure 2.2: Overview of the procedure for calculations with Q. The white boxes repre-
sents files and typical file name extensions.
tions with Q one must prepare coordinates for the system that are in the correct
format for Q, and a topology must be created for the system. The topology file
is prepared with Qprep and contains all the information about the molecular
system needed for running a simulation with Qdyn. Qcalc and Qfep can be used
for analyzing the resulting trajectories, extracting energies, calculating free en-
ergies etc. depending on what type of simulation one has run and what type of
information that is desirable.
Missing parameters and charges were assigned to all peptides according to
the OPLS2005 all-atoms force field [137] with MacroModel Version 9.6 [114].
The topology was then prepared with Qprep5. The simulation center was de-
fined as the Cα atom of the second amino acid residue counting from the N-
terminal (the X residue in Figure 1.12). Each peptide was immersed into a
spherical droplet of explicit water molecules with a radius of 25 Å centered at
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the simulation center (Cα). Water molecules were described using the TIP3P
model [138]. The Cα peptide atom (simulation center) and water atoms in the
outermost 4.2 Å were weakly restrained to their initial positions with a harmonic
potential of 5.0 kcal/(mol Å2). The nonbonded potential was truncated at 10
Å for solvent-solvent interactions. Long-range electrostatics were treated using
a multipole expansion method [139]. The peptide-solvent interactions were not
truncated and the peptide was thus allowed to interact with the entire system.
All systems were heated from 1 K to 300 K using a stepwise scheme, followed
by an equilibration period of 500 ps. The step size was also gradually increased
from 1 fs to 2 fs, whereas the bath coupling was increased from 1 to 10 during
the heating. SHAKE [91] was used to constrain bonds and angles on solvent
molecules, but not on the solute. A time step of 2 fs was used for the produc-
tion phase, and the temperature was maintained at 300 K using a weak coupling
to the bath. The production phase consisted of 50 ns and conformations were
sampled every ps. A total of 3 such simulations were run for each tripeptide,
differing in distributions of initial velocities, giving a final simulation time of 150
ns. All calculations were done on the NOTUR supercomputer STALLO [140].
Each calculation was submitted on eight processors and took around 12 days to
finish.
The resulting trajectories were inspected with the Visual Molecular Dynam-
ics program VMD [141]. To locate highly populated regions with stable con-
formations the RMSD (Eq.2.1) for each sampled conformation was calculated







; di = |xi − x′i| (2.1)
The RMSD plot was used to locate regions in the trajectory time line with fa-
vorable conformations. Once located, 10 ps from the populated regions were ex-
tracted with VMD. The current potential OPSL2005 energy for the correspond-
ing conformations from these regions were then calculated with MacroModel
using water as solvent. After calculating the current energy, the structures were
energy minimized with OPLS2005 using water as solvent. All calculations were
performed with the TNCG (Truncated Newton Conjugate Gradient) [142] op-
timization scheme and was chosen to converge on the gradient with a value of
0.001.
2.3.2 Membrane simulation
Peptide membrane interactions were studied with molecular dynamics simu-
lations by using the parallel version of the MD program Desmond [143, 144].
The system was prepared with a 1-palmitoyl-2-oleoyl-glycero-3-phosphoethanol-
amine (POPE) membrane and explicit SPC [145] water molecules. The simula-
tion was performed in an orthorhombic box (∼ 30× 36× 100 Å) where the box
boundary was controlled by a buffer distance set to 10× 10× 10 Å between the
solute structure and the simulation box. The final peptide:lipid ratio was 1:42.
The system was neutralized by adding Cl− ions which were excluded within 7
Å of the cationic peptide to avoid peptide ion interactions. In order to study
the mechanism of how the peptide approaches and enters the membrane, the
peptide was manually placed outside the membrane with a peptide membrane
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Figure 2.3: Illustration of the starting conformation for the membrane simulation. Pep-
tide placed outside the POPE membrane (illustrated with red boxes).
distance of ∼3 Å as illustrated in Figure 2.3. All calculations were performed
with the NPT ensemble at a temperature of 310 K and a pressure of 1 atm.
The NPT ensemble was calculated with the Nose-Hoover [146, 147] thermostat
method, with a relaxation time of 1.0 ps and a frequency update every sec-
ond step, and the Martyna-Tobias-Klein [148] barostat method, using isotropic
coupling with a relaxation time of 2.0 ps and a compressibility of 4.5 · 10−5
(1/bar). Coulombic short range interactions were treated with a cutoff radius
of 9 Å. Long range interactions were treated with the smooth Particle Mesh
Ewald method [149] with a tolerance of 10−9. Simulations of 50 ns were sub-
mitted using the RESPA (reference system propagator algorithm) time-stepping
scheme [150] with time-steps set to 2 fs for bonded and near atoms and 6 fs for
far atoms. Heavy atom-hydrogen covalent bonds were constrained with a shake
tolerance of 10−8 with a maximum of 8 iterations.
2.4 Docking experiments
The docking program Glide [97] from Schrödinger was used to generate models
of the peptide-chymotrypsin complex and the corresponding free energies of
binding. Glide offers the possibility for docking and scoring a wide variety of
ligands with different methods ranging from HTVS (high throughput virtual
screening) for fast results to XP (extra precision) docking for more demanding
calculations of the ligand-protein interaction. The search algorithm in Glide is
based on a hierarchical filter, illustrated in Figure 2.4, that score hydrophobic
and polar interactions followed by a Monte Carlo sampling. In general only
a small number of the best refined poses is passed on to the third stage for
energy minimization on the pre-computed OPLS-AA [137] van der Waals and
electrostatic grid for the receptor. The minimized poses are in stage 4 re-scored
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Figure 2.4: Illustration of the Glide docking hierarchy.
with Schrödingers GlideScore scoring function given as:
∆GGScore = 0.065 · vdW + 0.130 · Coul + Lipo+Hbond (2.2)
+ Metal +RotB +BuryP + Site
Here Coul stands for Coulomb energy, Lipo the lipophillic contact term, vdW
for van der Waals energy, HBond is the hydrogen-bonding term, Metal the
metal-binding term where only the interactions with anionic acceptor atoms are
include, BuryP is the penalty for buried polar groups, RotB is the penalty for
freezing rotatable bonds, and site is the polar interactions in the active site
term.
Coordinates for chymotrypsin were obtained from the crystal structure of
the P1 Trp BPTI mutant- bovine α-chymotrypsin complex with the entry code
1t8o [46] from the Protein Data Bank, PDB [69]. The protein was prepared
for the docking experiment in Maestro 9.0 [113] using the protein preparation
wizard. The preprocess was run to assign bond orders, add hydrogens, treat
metals and delete water molecules beyond 5 Å from protein heavy atoms. After
the preprocess was run the protein was prepared using the Interactive Optimizer.
The Analyze Network was run with the Include Current Orientations selected.
The Optimize All was then run with high degree of sampling selected. His57
was found to be in the protonated state (Hip) with H-atoms bound to both
Nδ and Nε. The hydroxyl hydrogen of Ser195 was also found to be oriented
incorrectly as expected when His57 was in the protonated state. Hip57 was
changed to Hid57 and the hydroxyl hydrogen from Ser195 was oriented towards
Nε of Hid57, as illustrated in Figure 2.5. Finally the hydrogen bonding network
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(a) Inital orientation (b) Final orientation
Figure 2.5: Orientation of the hydroxyl hydrogen from Ser195 in the active site of Chy-
motrypsin when changing Hip57 to Hid57.
was optimized with exhaustive sampling and sampling of water orientations
prior to docking.
The receptor grid was prepared with Glide version 5.5 [97]. The P1 Trp BPTI
ligand was truncated to only include the three residues 14-16 where residue 15 is
Trp. These three residues are expected to be similar to the target peptides in this
study, and were therefore specified as a ligand molecule in the grid generation.
This truncated tripeptide defined the center of the grid box, and glide was set
to dock ligands similar in size to this peptide. The van der Waals radius scaling
was set to a scaling factor of 1.00 and a partial charge cutoff of 0.25. The grid
was also prepared to allow rotation of the receptor hydroxyl groups Ser189 and
Ser195.
Figure 2.6: Core atoms selected from the reference ligand Trp BPTI. Yellow boxes
illustrate the selected atoms for the SMART pattern.
All calculations were performed with the extra precision (XP) mode. The
calculations were set to dock flexibly and to sample ring conformations. Non-
planar amide bonds were penalized. Scaling of van der Waals radii on the ligands
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was selected with a scaling factor of 0.80 and a partial charge cutoff of 0.15. For
the Glide screens 10 000 poses per ligand were specified to be kept for the initial
phase of the docking calculation. The scoring window for keeping the initial
poses was set to 100 kcal/mol. The 1000 best poses per ligand were kept for
energy minimization with a maximum number of conjugate gradient steps set to
5000. A maximum of one million ligand poses per docking run and 20 poses per
ligand were collected. Glide was also set to perform post-docking minimization
with 2000 poses per ligand included. The threshold for rejecting minimized
poses was set to 0.50 kcal/mol. The docking calculations were performed both
unconstrained and constrained. In the constrained docking calculation, 8 atoms
from the truncated P1 Trp BPTI were selected as core atoms as illustrated in
Figure 2.6. The selected atoms defined a SMARTS pattern and the calculations
were restricted to dock to the reference position with a tolerance of 1 Å. The best
poses were subjected to a refinement calculation where the key descriptors and
per-residue interaction scores within 12.0 Å of the grid center were calculated.
2.5 Gelfiltration and SDS-PAGE
The α-chymotrypsin purity was inspected with gelfiltration and SDS-PAGE
prior to the isothermal titration experiments. A reference calibration curve
was prepared by mixing 40 µl each of aprotin (6.5 kDa), ribonuclease A (13.7
kDa) and carbonic anhydrase (29 kDa) from the GA Healthcare Gelfiltration
Calibration kit LMW to a total volume of 200 µl in filtered and degassed 0.1 M
NH4HCO3 buffer (pH 8.2). 0.2 ml of the mixed reference solution was injected
into an ÄKTAExplorer (GE Healthcare) and eluated through a Superdex 200
10/300 GL size exclusion column with a flow rate of 0.5 ml/min (0.66 MPa).
The absorption was measured at 260 nm and 280 nm. α-chymotrypsin was
dissolved to a final concentration of 31 mg/ml in filtered and degassed 0.1 M
NH4HCO3 buffer (pH 8.2) and run through the column in the same way as the
reference solution. Fractions of 0.5 ml were collected between 12 ml and 33 ml
based on the absorption curve for further analysis with SDS-PAGE.
15 µl of each collected sample was mixed with 15 µl of loading buffer. The
loading buffer was prepared by mixing 0.5 ml of 4x LDS New-PAGE loading
buffer, 0.4 ml mQ-H2O and 0.1 ml Betamercapto EtOH reducing agent. The
mixed solutions were then incubated for 5 minutes at 95oC. The SDS-PAGE
was run for 40 minutes with 150V together with 7µl molecular weight ladder
Mark12 as reference.
2.6 Isothermal Titration Calorimetry
The heats of interaction were determined using a CSC 5300 nano-isothermal
titration calorimeter III with a 1 mL cell volume (Calorimetry Sciences Corp.,
UT). The experiments were set up with 20 aliquots of 5 µL peptide (2.1 mM)
added to a stirred (150 rpm) solution of α-chymotrypsin (0.1 mM) in an aqueous
buffer at 25oC. The reaction cell was allowed to equilibrate for 400 s before the
titration was started. 400 s intervals were used between each injection to allow
the interacting species to reach equilibrium. The buffer solution used was 0.1 M
NH4HCO3 at pH 8.2. The heats of dilution were determined in a similar fashion
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where the peptides were added to a stirred buffer solution without protein.
Subtraction of the dilution heat yielded the heat of interaction and a binding
isotherm from which the association constant and complex stoichiometry were





Native crystals of α-chymotrypsin were grown by the hanging drop vapor dif-
fusion method at room temperature. Drops consisted of a mixture of protein
solution (30 mg/ml in distilled water), reservoir solution (10 mM sodium ca-
codylate pH 6.0 and 45-50% ammonium sulfate) and 1 M NaI. These were mixed
in the ratio protein:reservoir:NaI = 5 µL:4 µL:1 µL, as described by Moulin et
al. [151]. The protein solution was first pipeted onto a glass cover slip, then the
reservoir solution was added, and finally the NaI solution was added. The drop
was not mixed mechanically, but allowed to self-mix by simple diffusion. The
well was filled with 700 µL of reservoir solution.
Soaking
Crystals of native α-chymotrypsin were, after growing to their final size, soaked
in a solution of 20 mM sodium cacodylate (pH 7.4), 70% ammonium sulfate and
3 mM tripeptide for 2-3 weeks.
2.7.2 Data collection
Native crystals
Data of native crystal were collected at our home facilities with an R-AXIS IV
image-plate detector (Rigaku, Japan) operating at 50 kV and 100 mA with a
copper anode, to a final resolution of 1.8 Å. Crystals were harvested by passing
them through a cryo solution of 22% PEG 3350 and 15% MPD in water before
placing them in the beam where they were protected against radiation damage
by a liquid nitrogen spray at a temperature of 100-120 K. Exposure times were
150.0 s with an incident wavelength of 1.5418 Å and an oscillation sweep of 0.5o.
A total of 300 images were collected. The data were indexed and integrated
using XDS [152] and scaled with SCALA from the CCP4i [153] program suite
(Collaborative Computational Project 4).
Soaking
Crystals left in soaking solution with RWAgp-NHBn were harvested and col-
lected after two weeks at our home facilities as previously described to a final
resolution of 2.1 Å. The exposure time was 300 s and a total of 360 images were
collected.
Crystals soaked with RBipR-NHBn were collected after 3 weeks. They were
passed through a cryo solution of 22% PEG 3350 and 15% MPD in water and
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flash frozen in liquid nitrogen. Data was collected in Grenoble on the syn-
chrotron beamline ID29 with a wavelength of 1.240 Å and an oscillation sweep
of 0.5o to a final resolution of 1.8Å. The exposure time was 0.20 s with a trans-
mission of 19%. Data were indexed with Mosflm [154] and scaled with SCALA.
2.7.3 Refinement
Molecular replacement was performed with the maximum likelihood program
Phaser [155]. Phases were derived from a starting model taken from the Protein
Data Bank with entry code 1t8o [46]. A rigid body refinement followed by a
restrained refinement was then performed with Refmac5 [156] applying default
geometric parameters. The model quality was checked and adjusted manually
in Coot version 0.6 [157] with the help of the electron density maps FO − FC
and 2F0 −FC . Refmac5 was used to refine the structures after manual changes
introduced in Coot in a reiterated procedure. Finally a restrained refinement
was run with Refmac5 with Coot [157] set to automatically add/delete waters.
The structures were evaluated with PROCHECK [158] and by superimposing
the structures on the deposited 1t8o structure with the program LSQKAB [159].
A temperature factor analysis was performed with BAVARAGE in the CCP4i
program suite [153].
“If you’re not part of the solution, you’re part of the precipitate.”
−Henry J. Tillman
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3.1 Conformational structures of tripeptides
It has previously been reported that one of the key features for antimicrobial
activity of AMPs is that they must exhibit a suitable amphipathic structure
in addition to a net positive charge for efficient membrane binding [11]. These
features have however been suggested based on information from much larger
AMPs (∼30 residues) than the small tripeptides from our research group. It was
therefore of interest to examine the conformations of these peptides to see if they
exhibit an amphipathic structure. As a step in investigating the properties of the
tripeptides the three dimensional structure was examined using computational
methods.
3.1.1 Geometry optimization with DFT fails
All tripeptides in this study have several aromatic regions which can give rise to
internal stacking or packing. The chosen B3LYP [83] functional has previously
been reported to fail in predicting the minima of stacked complexes [160]. The
X3LYP functional [161] on the other hand was designed to describe non-covalent
interactions, but Cerny and Hobza showed in their work that the X3LYP func-
tional fails when locating the minima of dispersion-dominated stacked structures
of nucleic acid pairs [160]. Recently Zhao et al. [123] reported a new functional
called M05-2X that is claimed to greatly improve the performance for non-
covalent interactions compared to previously DFT methods. It was therefore
decided to geometry optimize the tripeptides with both M05-2X and B3LYP to
see if there were any significant differences between the two functionals.
It was difficult to obtain convergence and most of the calculations crashed or
died. Inspection of the output files showed very big fluctuations in the energies
and forces, indicating problems with the cavity generation. Different ways of
specifying the cavity were therefore tested with Gaussian03 where one or more
of the following options for the cavity generation were used:
• Using sphere radii from the UFF force field, instead of the default UAO
(RADII=UFF).
• Making the tessera larger to 0.4 instead of 0.2 which is default
(TSARE=0.4).
• An older, and sometimes better, way of creating the cavity was tried by
including the keyword OLDGEPOL.
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• The NOADDSPH keyword meaning that spheres are not going to be added
to smooth cavity was also tried.
However, this did not work either. In addition to the cavity problem, other
methods like OLYP [120, 121, 162, 163] and HF [164–166] with both smaller
and bigger basis sets were tried without any success. ADF [167] with OLYP
and the STO-DZP basis set was also tested with the COSMO solvation model,
but did again not converge.
Three protons from the tripeptides were also removed in an attempt to op-
timize uncharged molecules. The idea was that if the neutral molecule would
converge to an optimized geometry in solvent, one could use that geometry and
add one proton at a time between each new successive optimization. Unfortu-
nately, this did not work either.
Peptides were however geometry optimized using both B3LYP and M05-2X
along with the 6-31G(d,p) basis set in gas phase without any problems. It
therefore appears to be quite clear that the solvent models offered in Gaus-
sian03, Jaguar and ADF are not appropriate for dealing with molecules like
these cationic tripeptides. We therefore decided to use other methods to inves-
tigate the peptide conformations.
3.1.2 Identification of stable structures in the MD simu-
lations
As an alternative to geometry optimization with DFT, it was decided to investi-
gate the phase space with molecular dynamics simulations. Simulations of 50 ns
were run three times with the OPLS-AA force field for each peptide with the MD
program Q. This was done by placing the peptide in a 25 Å simulation sphere
of explicit water molecules. The stability of the simulations were inspected by
checking the total energies and the solute-solvent interaction energies from the
simulations. The total kinetic and potential energies were found with averages
around 3800 and -19300 kcal/mol, respectively, for all peptides (Table 3.1). The
total temperature for all simulations was 300 K ±5 indicating that the bath cou-
pling is not too hard. The potential OPLS-AA interaction energies between the
Table 3.1: Q energies for selected petides (kcal/mol.
Peptide Q-Surr.a SUM Energiesb
el. vdW Total Potential Kinetic
RBipRNH2 -596.5 -11.2 -15582.0 -19415.5 3833.2
RBipR-NHBn -586.3 -20.3 -15552.7 -19362.1 3809.4
RTbtR-NHBn -585.7 -35.3 -15473.9 -19327.3 3853.4
RWR-NH2 -595.7 -11.2 -15674.7 -19495.7 3821.0
RWR-NHBn -586.2 -20.3 -15583.1 -19407.7 3824.7
a Peptide solvent interaction energies in kcal/mol taken as an average over
150 ns.
b Sum of energies in kcal/mol taken as an average over 2.5ns.
peptide and solvent have average electrostatic interaction energies between -580
to -600 kcal/mol and vdW energies between -15 to -20 kcal/mol. In Figure 3.1
60
3. RESULTS AND DISCUSSION
Figure 3.1: Peptide-solvent interaction energies in kcal/mol as observed in the MD sim-
ulations of RBipR-NH2. Green is electrostatic interactions and red is vdW interactions.
the time development of the electrostatic and vdW solute solvent interaction en-
ergies are illustrated. The total energies, the temperature and the solute solvent
interaction energies thus support that the simulations were stable.
In order to locate highly populated regions in the conformational space,
the RMSD was calculated with the minimized starting structure as reference
for each simulation. The RMSD plots from the 150 ns simulation time revealed
that all the tripeptides had two or more highly populated regions in the explored
conformational space, which indicates stable conformations. The RMSD plot for
RBipR-NH2 is illustrated in Figure 3.2 and shows how the simulation oscillates
around 2 to 3 such conformations. This was also supported by visualizing the
Figure 3.2: RMSD plot for RBipR-NH2 from the 150 ns MD simulation in solvent (water).
MD trajectories with VMD [141] where it was found that the peptides stay more
or less in one conformation before they completely change into the next.
After extracting and inspecting conformations from the most populated re-
gions, it was found the tripeptides indeed do exhibit an amphipathic structure
in at least one of the explored regions, but not in all of them. One of the most
interesting results obtained from the MD simulations was that the peptides, es-
pecially those with two bulky groups, have at least two highly populated regions
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(c) Not amphipathic (one
face)
Figure 3.3: Face flipping: RBipR-NHBn going from an amphipathic conformation to a
non-amphipathic conformation.
from the RMSD plot corresponding to conformations the peptide can switch be-
tween. In one region the peptides were found with an amphipathic structure
(two faces) and in the other with non-amphipathic structure (one face). This in-
dicates that the peptides are able to go from having only one face to having two
faces, which will be referred to as face flipping. RBipR-NHBn is illustrated in
Figure 3.3 with three different favorable conformations, observed in the simula-
tion, resulting in face flipping. All peptides were found to alter between different
conformations (Figure 3.4), but the face flipping property is most prominent for
peptides with two bulky groups (in this case the additional benzyl group on the
C-terminal). Interestingly, the MIC values (Table 3.2) also show that peptides
Figure 3.4: 10ps from the most obvious stable regions found from the RMSD plots
superimposed on each other.
with benzyl as a C-terminal capping group are far more efficient than those
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with the amino modified C-terminal. In some cases a ten-fold reduction in MIC
values is observed when introducing benzyl as the C-terminal capping group
[168]. Based on the simulations it is clear that the C-terminal benzyl group
makes the difference between the amphipathic and non-amphipathic structures
larger when compared to simulations with the C-terminal amide group.
Table 3.2: Antibacterial activity of selected peptides as MIC valuesa
Peptide MIC (µg/mL)
S.aurerusb MRSAc E. coli
RWR-NH2 >150 n.a >150
RWR-NHBn 75 125 >150
RBipR-NH2 >150 50 n.ad
RBipR-NHBn 10 15 >150
RBipGpp-NH2 75 50 n.ad
RBipGpp-NHBn 5 5 100
GppBipR-NH2 75 50 n.ad
GppBipR-NHBn 5 5 100
RTbtR-NH2 7.5 7.5 60
RTbtR-NHBn 2.5 2.5 7.5
a Data from refs. 168, 169 and 110
b S. aurerus strain ATCC 25923
c Methicillin resistant S. aurerus strain ATCC 33591
d Data not available
In light of the few populated conformations observed for the peptides, the
next question addressed was how easily the peptides can move between the dif-
ferent conformations. In order to obtain an estimate of the energy required for
the peptides to change between different conformations, instantaneous struc-
tures from stable regions were extracted and the current energy was calculated
with MacroModel [114]. After calculating the potential energy, the structures
were energy minimized in order to optimize the geometry. The minimization
resulted in fixing of non-planar hydrogens and bad torsions. The potential en-
ergies and the RMSD between the MD and the minimized conformation for
selected peptides are summarized in Table 3.3. The minimization procedure
did not change the overall conformation of the peptides, as revealed by the
low RMSD values (Table 3.3). After minimization, the energies of the different
conformations of each peptide were found to be surprisingly similar and only
separated by 3.3 - 0.2 kcal/mol. The small energy difference between the con-
formations indicates that they are equally stable and thus quite flexible between
each favorable conformation. RTbtR-NHBn goes through face flipping as illus-
trated in Figure 3.4, with an energy difference between the two conformations
of approximately 0.2 kcal/mol. The low energy difference suggests that the pep-
tide has an amphipathic and non-amphipathic conformation of equal stability.
Interestingly, this particular peptide is also the most potent examined here.
The face flipping property and the low energy difference between different
conformations suggest not only that the peptides are flexible, but also led us to
believe that this might be a key features for the peptide to interact with a cell
membrane. The CAPs may interact with a bacterial cell membrane with one
face of the amphipathic structure and then switch conformation as it enters the
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Table 3.3: Potential OPLS2005 energies (kcal/mol) of selected peptides before and
after energy minimization and the corresponding RMSD (Å).
aPeptide aConf. bCurrent Energy cMinimized Energy dRMSD
RWR-NHBn 1 -214.7 -286.6 0.9175
RWR-NHBn 2 -217.5 -287.1 1.4449
RWR-NH2 1 -246.2 -299.7 1.9282
RWR-NH2 2 -240.4 -299.3 0.5097
RBipR-NHBn 1 -203.6 -271.2 1.0646
RBipR-NHBn 2 -197.8 -267.9 1.4019
RBipR-NHBn 3 -189.3 -269.9 1.3215
RBipR-NH2 1 -229.1 -285.5 1.5568
RBipR-NH2 2 -217.2 -289.1 1.2725
RTbtR-NHBn 1 -186.7 -277.9 1.0671
RTbtR-NHBn 2 -180.1 -278.1 1.1811
a Peptide and numbers corresponding to those illustrated in Figure 3.4.
b Potential OPLS2005 energy for the unoptimized peptide extracted from the MD
trajectory.
c Potential OPLS2005 energy for the energy minimized peptide extracted from the MD
trajectory.
d RMSD between unoptimized and optimized peptide.
membrane with its flexible motions. These interesting results prompted us to
investigate their mode of interaction with cellular model systems in more detail.
3.2 Face flipping and its implications for mem-
brane interactions
Peptide membrane interactions were studied with molecular dynamics sim-
ulations using a 1-palmitoyl-2-oleoyl-glycero-3-phosphoethanolamine (POPE)
membrane and explicit SPC water molecules. The simulations were initiated
with the peptide placed outside the membrane (Figure 2.3) in order to study
the mechanism of how the peptide approaches and potentially enters the mem-
brane. The time development of the peptide-membrane vdW and electrostatic
interaction energies observed in simulation of RBipR-NHBn are illustrated in
Figure 3.5. The total peptide membrane interaction energies varied between
-40 to -470 kcal/mol through the simulations with an average of around -260
kcal/mol. The vdW interactions were found to vary between 12 and -63 kcal/mol
and the Coulombic interaction energies between 0 and -190 kcal/mol, depending
on the peptide position relative to the membrane. During the first nano seconds
of the simulations, the tripeptides were found to exhibit an amphipathic struc-
ture with the charged arginine groups oriented towards the head groups of the
POPE membrane. After approximately 10 ns the peptides began, with their
characteristic flexible movemens, to insert the benzyl group of the C-terminal
into the membrane as illustrated in Figure 3.6 for RBipR-NHBn. This can also
be seen from the plot for the vdW interaction energies for RBipR-NHBn in Fig-
ure 3.5 where the energies are close to zero until ∼10 ns. After that the vdW
interaction energies decrease from around -5 kcal/mol to around -50 kcal/mol
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Figure 3.5: Peptide membrane vdW (top) and Coulombic (bottom) interaction energies
for RBipR-NHBn (kcal/mol).
at ∼30 ns. In the interval between 25 and 30 ns RBipR-NHBn entered the
membrane bilayer with the hydrophobic Bip residue pushing the hydrophilic
head groups of the membrane out of the way (Figure 3.6). After approximately
30 ns RBipR-NHBn was found with both hydrophobic groups inserted into the
membrane bilayer as illustrated in Figure 3.6. For the rest of the simulation, the
peptide was found with an amphipathic structure with the hydrophobic groups
buried in the membrane bilayer and the charged argenine groups anchored at
the membrane surface interacting with the polar head groups. This can also be
seen from the vdW plot in Figure 3.5 where the interaction energies becomes
more or less stable around -50 kcal/mol during the last 20 ns of the simulation.
The rate of how fast the petides entered the membrane with both hydropho-
bic groups was found to vary between the simulations. All peptides studied
successfully inserted the benzyl group of the C-terminal into the membrane bi-
layer quite fast (around 10 ns), but not all managed to perform the face flipping
mechanism to get both hydrophobic groups into the membrane within the 50 ns
simulation time. RDipR-NHBn, illustrated in Figure 3.7, for example showed
the same mechanism as described above, but did not manage to bury the Dip
residue in the membrane bilayer within the 50 ns of simulation. It is however not
energetically favorable for such a hydrophobic residue as Dip to be left exposed
65
3. RESULTS AND DISCUSSION
Figure 3.6: RBipR-NHBn entering the POPE membrane with the face flipping mech-
anism. a) Face flipping transition entering the membrane with the C-terminal benzyl
group. b) Polar headgroups of the POPE membrane pushed out of the way as RBipR-
NHBn flips the hydrophobic Bip residue into the membrane. c) Both hydrophobic groups
buried in the membrane bilayer and the charged argenine residues anchored at the
membrane surface.
to the polar environment of solvent (water) and the membrane head groups.
The simulations provide good support to the hypothesis that the peptides
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Figure 3.7: RDipR-NHBn with the C-terminal benzyl group buried in the membrane
bilayer.
perform the face flipping mechanism as they enter the membrane. This means
that they switch between amphipathic and non-amphipathic conformations in
order to break through the polar membrane surface. The flexible peptide move-
ments were also found to be quite effective in pushing the lipids out of the way
as the peptide enters the membrane. The cationic charges seem to be very
important as they interact strongly with the negatively charged parts of the
membrane head groups. This will as a first step pull the peptide towards the
membrane surface and make it stay there. This however leaves the peptide with
its hydrophobic groups exposed to the solvent, which is not very favorable. It is
therefore just a matter of time before the peptide flips its hydrophobic groups
into the membrane bilayer. Previous studies have suggested the possibility for
peptide interactions with intracellular targets [23, 24], but these simulations
showed that the peptide is prevented from moving further into the membrane
bilayer because the cationic charges work as an anchor at the polar membrane
surface (Figure 3.6). If the peptides are going to cross the membrane bilayers
and enter the cell, some sort of pore is required, but these preliminary studies
indicate that the CAPs get “stuck” in the membrane bilayer and interactions
with intracellular targets does not seem to be the primary mode of action. The
results thus indicate that the flexible cationic tripeptides are pulled towards
the membrane where they perform the face flipping mechanism to enter the
membrane with their hydrophobic groups.
3.3 Refining the pharmacophore
All peptides studied here, except from RWR-NH2, fulfil the previous reported
minimum motif (two cationic charges and two hydrophobic bulk units) for an-
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timicrobial activity, but the reported MIC values (Table 3.4) varies a lot. One
Table 3.4: Antibacterial activity of selected peptides as MICa values compared with
peptide volumes and surface areas.
Peptide MIC (µM) Vd FOSAe PISAf FISAg
S.aurerusb MRSAc (Å3) (Å2) (Å2) (Å2)
RTbtR-NHBn 3.2 3.2 2328 613 144 315
RBipR-NHBn 10 15 1901 240 368 306
RDipR-NHBn 25 10 1958 223 414 354
RWGpp-NHBn 50 10 1928 173 396 354
RGppW-NHBn 50 15 1909 204 356 380
RWAgp-NHBn 54 16 1739 210 289 405
RWR-NHEtPh 52 26 1950 246 340 428
RRW-NHBn 79 26 1809 258 274 383
RWHar-NHBn 78 52 1923 280 274 423
RWOrn-NHBn 110 55 1688 257 293 291
RWR-NHBn 79 132 1871 253 293 425
RWK-NHBn 163 54 1809 299 290 425
RWApp-NHBn 157 79 1791 195 398 291
RAppW-NHBn 157 79 1828 191 397 317
RFR-NHBn 165 83 1816 276 288 422
RWR-NH2 >200 >200 1544 223 158 415
a MIC data from refs.110 and 169
b S. aurerus strain ATCC 25923
c Methicillin resistant S. aurerus strain ATCC 33591
d V, Volume
e FOSA, Hydrophobic surface area
f PISA, π surface area
g FISA, Hydrophillic surface area
intersting question arising from this is what chemical features of the peptides
determine how effective they are going to be in killing a microbe. A range
of molecular properties were therefore calculated with QikProp [170] and com-
pared with experimental MIC values. Some of the most interesting properties
that correlate with the MIC values were the total solvent accessible volume, the
hydrophobic (FOSA) and the hydrophilic (FISA) solvent accessible surface area
(SASA) as shown in Table 3.4. The π component of the SASA (PISA) includes
carbon and attached hydrogen, whereas the FOSA includes saturated carbon
and attached hydrogen. FOSA, PISA, and FISA thus creates the total solvent
accessible surface area where FOSA and PISA accounts for the hydrophobic and
FISA the hydrophilic part of the SASA.
The total peptide volume seems to play an important role on the MIC values
as illustrated in Figure 3.8 where the peptide volumes have been plotted against
the avarage MIC values from Table 3.4. It also seems that the hydrophobic part
(FOSA+PISA) of the SASA plays an important role on the MIC values (Figure
3.8). RTbtR-NHBn is in this study the peptide with the best MIC values,
and also the one with both the largest volume and the largest hydrophobic
surface area (approximately 71% of the total SASA). RWR-NH2 is the only
peptide in this study that display no antimicrobial activity against S. aurerus
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Figure 3.8: a) The calculated total solvent accessible peptide volume (Å3) plot-
ted against the average MIC values from Table 3.4. b) The total hydrophobic
(FOSA+PISA) and hydrophilic part of the solvent accessible surface area plotted against
the BAVARAGE MIC values from Table 3.4.
or MRSA. Interestingly, this peptide has not only the smallest volume, but also
the smallest hydrophobic part of the SASA. Moreover, RWR-NH2 is the only
peptide from Table 3.4 that has a larger hydrophilic (∼52%) than hydrophobic
(∼48%) solvent accessible surface area.
The results from the membrane simulations show that the tripeptides enter
a bacterial cell membrane with the face flipping mechanism. These preliminary
studies also suggest that the peptide volume and composition of hydrophobic
and hydrophilic domains play a very important role on the antimicrobial prop-
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erties. It thus seems that the hydrophobic solvent accessible surface area is




The protein purity was inspected prior to experiments to estimate the pro-
tein purity. that it was pure enough to work with. The UV 280 and 260 nm
Figure 3.9: Absorption curves of α-chymotrypsin eluated through a Superdex 200
10/300 GL size exclusion column with a flow rate of 0.5 ml/min. Red line is UV 260
nm and blue curve is UV 280 nm. The collected samples (1-42) are illustrated on the
x-axis.
gelfiltration spectrum of the elutant, illustrated in Figure 3.9, confirmed, af-
ter comparing with the reference molecular weight proteins, that the protein
is pure and homogeneous. The first big absorption top at 18.4 ml is ∼25 kDa
which is the molecular weight of chymotrypsin. The two small and connected
absorption tops at 22.3 ml and 23.3 ml are both smaller than 6.5 kDa, because
the absorption top of the reference protein with molecular weight 6.5 kDa came
before 22.3 ml. The first top at 22.3 ml is ∼4 kDa and the second at 23.3 ml is
∼1.0 kDa. α-chymotrypsin is divided into the three chains A (Cys1-Leu13), B
(Ile16-Tyr146), and C (Ala149-Asn245), which are linked together with disulfide
bridges. The last two small absorption tops might be Cys1-Leu13 which has a
weight of ∼1.2 kDa, either as monomers for the last top or dimers for the first
top. These tops are however very small compared with the main top which is
from α-chymotrypsin.
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The collected fractions 15-37 from the gelfiltration were run on SDS-PAGE
together with a Mark12 ladder (M) and a sample of chymotrypsin (R) that
had not been gelfiltrated. The result from the SDS-PAGE is illustrated in
Figure 3.10. The band between 31 kDa and 21.5 kDa corresponding to the
Figure 3.10: SDS-PAGE of α-chymotrypsin. M is the Mark12 ladder and R is a ref-
erence solution of α-chymotrypsin that has not been gelfiltrated. The numbers 15-37
are the respective numbers of the collected samples from the gelfiltration illustrated in
Figure 3.9.
molecular weight of chymotrypsin of 25 kDa is very weak both for the refer-
ance chymotrypsin (R) and from the collected fractions (15-37). There are two
strong bands both from the reference protein and the collected samples between
14.4 kDa and 6.0 kDa. These bands are most likely ∼14 kDa and ∼10 kDa
which are good matches for chain B (Ile16-Tyr146, ∼13.9 kDa) and chain C
(Ala149-Asn245, ∼10.1 kDa) from α-chymotrypsin. Chain A, B and C are con-
nected with disulfide bridges, and the 5 minutes of incubating at 95 oC prior
to SDS-PAGE with the reducing conditions of β-mercapto is probably breaking
these connections. The SDS-PAGE results and the gelfiltration chromatogram
support the protein being pure and homogenous.
3.4.2 Docking and ITC
Chymotrypsin is a well studied proteolytic enzyme that plays a major role in de-
termining the fate of orally administrated peptides [171]. It has previously been
reported that the substrate specificity of chymotrypsin is defined by the prefer-
ential binding of a hydrophobic residue in the S1 pocket which is additionally
governed by a cationic side chain in the S1’ pocket [172]. Bearing the substrate
specificity in mind it is expected that the short cationic antimicrobial peptides
with hydrophobic residues are expected targets for chymotryptic degradation.
However, serine proteinases in general prefers at least six residues for optimal
substrate binding and catalysis [45], something that in theory should make the
tripeptides less suitable targets for chymotrypsin.
The binding modes of the peptides to chymotrypsin were investigated with
docking experiments using the Glide software[97] and with isothermal titration
calorimetry. The docking experiments were primarily carried out under the
requirement that the main-chain of the peptide should match the observed mode
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of the P2-P1’ segment of the P1 Trp BPTI bound to chymotrypsin to reduce
the number of false positives. BPTI is a transition state inhibitor of serine
proteinases and the interactions and geometric arrangement around the scissile
bond can be expected to resemble that of real substrates. Unconstrained docking
gives similar results with respect to the energies, but with many structural
solutions that can not lead to correct binding in the active site.
The free energies of binding obtained, presented in Table 3.5, ranged from
-3.6 to -10.6 kcal/mol. The results presented in the table are the top ranked
Table 3.5: Constrained docking results from Glide in XP mode (kcal/mol) ranged by the
experimental half life time (t1/2).








RWR-EtPh 0.5 -9.3 -1.9 -2.0 -6.2 W
RWHar-NHBn 1.1 -9.9 -1.3 -1.8 -7.7 W
RWR-NHBn 2.1 -10.6 -2.1 -2.0 -7.2 W
RFR-NHBn 3.3 -9.1 -1.8 -2.0 -6.3 F
RWK-NHBn 3.8 -10.4 -2.1 -2.0 -7.3 W
RWGpp-NHBn 4.5 -10.3 -1.5 -1.9 -7.5 W
RWR-NH2 4.6 -6.1 -2.1 -2.0 -5.6 W
RRW-NHBn 7.2 -6.6 -2.2 -1.9 -5.5 R
RAppW-NHBn 17 -9.4 -1.7 -1.7 -6.7 App
RWOrn-NHBn 20 -10.6 -1.8 -2.0 -7.5 W
RBipR-NH2 st. -8.1 -1.4 -1.8 -5.4 Bip
RWAgp-NHBn st. -10.4 -2.1 -1.9 -7.4 W
RWApp-NHBn st. -9.4 -1.3 -1.0 -7.9 W
RBipR-NHBn st. -9.1 -1.3 -1.7 -7.0 Bip
RGppW-NHBn st. -6.9 -1.6 -1.6 -7.1 Gpp
RDipR-NHBnc st. -8.9 -2.6 -2.6 -6.2 R
RDipR-NH2c st. -7.2 -1.7 -1.6 -4.8 R
RTbtR-NHBnc n.ad -3.6 -0.5 -1.5 -5.0 R
a t1/2 values are in hours (data taken from ref.110).
b Residue in the S1 pocket of chymotrypsin.
c Results are from unconstrained docking.
d Data not available.
solutions of constrained docking except for RDipR-NHBn, RDipR-NH2, and
RTbtR-NHBn where no binding mode was observed. The top ranked solution
for these are from the unconstrained docking. Based on the calculated free
energies of binding it is clear that the choice of X residue (Figure 2.1) has
varying impact on the binding to chymotrypsin. Going from RWR-NHBn to
RAppR-NHBn reduces ∆Gbind from -10.6 to -9.4 kcal/mol respectively. With
Bip as X (RBipR-NHBn) the free energy of binding is reduced to -9.1 kcal/mol,
whereas X = Dip (RDipR-NHBn), it is further reduced to -8.9 kcal/mol. Tbt
as X was found to bind in a much less favorable way compared to the other
tripeptides with a calculated free energy of binding of only -3.6 kcal/mol for
RTbtR-NHBn. Based on these results the following trend for the X residue
in RXR-NHBn is suggested upon binding to chymotrypsin where X is ranked
based on decreasing binding energies:
W > App > Bip > Dip > Tbt (3.1)
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Peptides with Tbt and Dip as X residues were however not found with any
poses within the applied constraints, and they are consequently scored with
poses from the unconstrained docking. Inspection of the results from docking
RDipR-NHBn revealed that an arginine was placed at the entrance of the S1
pocket, where it interacts with the side-chain of Ser195 (Figure 3.11). The Dip
Figure 3.11: RDipR-NHBn oriented incorrectly in the active site of chymotrypsin for
cleavage as revealed by docking experiments. The unfavorable arginine residue is in
the S1 pocket and the Dip residue is placed in the S2’ pocket.
residue is oriented in the S2’ pocket and the peptide backbone going in the wrong
direction for hydrolysis. ITC analysis of RDipR-NHBn did not yield a binding
isotherm that differed from that of the heats of dilution which is in support of
the results from the docking experiment. In a recent report, RDipR-NHBn was
also found to be stable towards tryptic degradation [36]. RDipR-NHBn is thus
a promising tripeptide for further development since it shows both good MIC
values (Table 3.4) and stability towards tryptic and chymotryptic degradation.
RBipR-NHBn on the other hand binds well to chymotrypsin but is also ori-
ented correctly for cleavage as illustrated in Figure 3.12. However, according to
the experimental half life time, this tripeptide is stable towards chymotryptic
degradation. After 24 hours only some trace amounts of product was observed
suggesting that this is a bad substrate for chymotrypsin. This may also indicate
that RBipR-NHBn is a potential inhibitor for chymotrypsin, something that is
not revealed by the RP-HPLC experiment. The ITC experiments suggest that
chymotrypsin binds RBipR-NH2 in a 1:1 complex (Figure 3.13). Peptides that
were sensitive to degradation by chymotrypsin could not be analyzed by ITC
due to the interfering heat contribution generated from the hydrolysis. The
calculated binding mode of RBipR-NHBn was however supported by the ITC
experiments which yielded a strong (KD = 18.4 µM) favorable stoichiometric
interaction (Table 3.6). One explanation for RBipR-NHBn being stable despite
its good fit in the S1 pocket might be that the Bip residue is too long com-
pared with the depth of the S1 pocket preventing the peptide from coming close
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Figure 3.12: A docked model of RBipR-NHBn suggesting that it fits nicely in the active
site of chymotrypsin acting as an inhibitor.
enough to the catalytic Ser195 for cleavage. In a recent report RBipR-NHBn
was however found to be rapidly degraded by trypsin with a half life of only 2
hours [36], making it a less attractive candidate for oral administration.
Table 3.6: Binding data from ITC runs.
Peptide KDa na,b ∆Ha,c -T∆Sa,c ∆Ga,c
(µM) (kcal/mol) (kcal/mol) (kcal/mol)
RBipR-NHBn 18.4 0.8 -1.8 -4.7 -6.5
RBipR-NH2 16.1 0.7 -5.4 -1.2 -6.6
RWAgp-NHBn 61.1 0.7 -1.0 -4.7 -5.7
aData from the ITC experiments and the binding isotherms. Avarage values based
on two parallel runs.
bStoichiometry of the interaction; experimental error is ±0.1.
cExperimental error is 15%.
The choice of C-terminal capping group (Z residue in Figure 2.1) was also
found to be very important in tuning the stability towards chymotryptic degra-
dation. The calculated free energy of binding for RBipR-NHBn is -9.12 kcal/mol,
whereas replacing -NHBn with - NH2, as in RBipR-NH2, reduces the free energy
of binding to -8.09 kcal/mol. The ITC experiment also showed a substantial
decrease in −T∆S from -4.7 kcal/mol to -1.2 kcal/mol upon the substitution
of -NHBn with -NH2 respectively for RBipR-Z (Table 3.6). It can also be seen
from the half life times that the Z residue greatly affect the stability of the CAPs
(Table 3.5). RWR-Z for example has a half life of 0.5 hours for Z = -NHEtPh,
2.1 hours for Z = -NHBn, and 4.6 hours for Z = -NH2. Based on the results
observed for RWR-Z the following trend for the Z residue is suggested upon
binding to chymotrypsin:
NHEtPh > NHBn > NH2 (3.2)
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Figure 3.13: Representive raw data from the ITC analysis of RBipR-NH2 (top figure)
into a buffered solution of chymotrypsin and into buffer only. The lower figure illustrates
the binding isotherm derived from the same run yielding a stoichiometric interaction and
very good fit to the one-site binding model employed. The data from the first point is
not included due to slow syringe leakage during the equilibration step prior to the first
injection.
Upon binding to chymotrypsin it is thus a trend towards destabilization fol-
lowing incorporation of longer C-terminal additions. This behavior is in clear
contrast to the results obtained from the previous trypsin study were the quite
opposite trend was observed [36]. This illustrates how the same structural mod-
ifications easily can alter the stability towards similar enzymes differently.
The choice of the Y residues (Figure 2.1), primarily targeting the S1’ pocket
of chymotrypsin, was found to have a surprisingly large effect on the stability
towards chymotrypsin. The calculated free energy of binding for RWR-NHBn
was -10.7 kcal/mol, whereas the very similar Har (one additional methylene
in its side chain) and Agp (one methylene less in its side chain) residues were
calculated with binding energies of -9.9 and -10.4 kcal/mol respectively. The
only difference between these three CAPs is the length of the Y residue (Arg ±
1 methylene) and consequently the calculated free energies of binding are very
similar. At a first glimpse the docking results suggest that RWAgp-NHBn and
RWHar-NHBn should be no less stable towards chymotryptic degradation than
RWR-NHBn (Figure 3.14). However, according to experimental half life times
RWY-NHBn is stable with Y = Agp, whereas for Har the half life is decreased to
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Figure 3.14: RWAgp-NHBn, RWR-NHBn and RWHar-NHBn superimposed in the ac-
tive site of chymotrypsin. The hydrogen bonds between the main chain carbonyls of
residues Phe41 and Cys58 in S1’ pocket are illustrated by dotted lines.
only 1.1 hours compared with Arg which has a half life of 2.1 hours (Table 3.5).
Based on the very similar binding modes of these three peptides, interactions
in the S1’ pocket seem to play a key factor in determining if the peptides are
hydrolyzed or not. These interesting observations prompted us to investigate
the residue specific interactions between the CAPs and chymotrypsin in more
detail.
The key interactions between selected peptides with different P1’ residues
and the S1’ pocket are presented in Table 3.7. The variation in the hydrophobic
interactions (vdW) showed no correlation to the half life times and were virtually
identical between the peptides and therefore only the Coulombic (electrostatic)
is given. The main interactions found that differed between the peptides were
Table 3.7: Residue specific interaction energies (kcal/mol).








RWR-NHEtPh 0.5 -9.3 -4.3 -6.9 -2.6
RWHar-NHBn 1.1 -9.9 -4.3 -6.6 -2.3
RWR-NHBn 2.1 -10.6 -4.8 -6.1 -1.3
RWR-NH2 4.6 -6.1 -5.3 -6.1 -0.8






the Coulombic interactions with the main-chain carbonyl oxygens of residue
Phe41 and Cys58, both part of the S1’ pocket. Interactions with Phe41 pulls
the peptide away from the catalytic Ser195, whereas interactions with Cys58
seems to counteract this. Based on the trend from the calculated energies it
is suggested that if the Coulombic energy is greater for Cys58 than for Phe41,
the peptide will be pulled towards the catalytic triad and cleaved, if not it will
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be stabilized and act as an inhibitor. This difference (∆Ecoul) explains the
difference of of interactions for the similar peptide side chains R, Har and Agp
in the S1’ pocket with good linearity (R2 = 0.9, data not shown) despite the
similar ∆Gbind values shown in Table 3.5. ITC control experiment on RWAgp-
NHBn was performed and confirmes that this tripeptide binds to the active
site in a stoichiometric manner similar to RBipR-NHBn with a dissociation
constant of 61.1 µM (Table 3.6). Interestingly, RWR-NHEtPh is the CAP in
this study with the shortest half life time and also the one with the largest
difference in Coulombic interaction energies between Phe41 and Cys58 (∆EXPcoul
= -2.55 kcal/mol). The calculated free energies of binding did not explain
Figure 3.15: RWR-NHBn and RWR-NHEtPh superimposed in the active site of chy-
motrypsin. The C-terminal capping moiety binds to the S2’ site giving rise to differences
it the residue specific interactions between the R side-chain and the S1’ pocket.
the destabilizing effect observed when replacing the Z capping group -NHBn
with -NHEtPh, but the residue specific interactions in the S1’ pocket did. It
thus seems that longer capping groups give rise to different interactions in the
S1’ pocket, favoring Cys58 and consequently hydrolysis (Figure 3.15). These
findings illustrates how the interactions in the S1’ pocket plays a decisive role
for the degradation of short cationic peptides with other residues available to
fixate the scissile bond in place over the active site.
Concerning the very short unusual peptides included in this study, the se-
quence dependence is not as pronounced and recent studies have shown that
confused peptides can yield the same antibacterial activities [168]. From a sta-
bility perspective this is an attractive drug design option and some peptides of
the form RXW-NHBn was therefore included in addition to the “native” RXR-
NHBn (X being a variable residue) providing peptides with a different overall
distribution of charge and bulk. From the MIC values presented in Table 3.4
it can be seen that RRW-NHBn, RAppW-NHBn and RGppW-NHBn display
similar antibacterial activities as the “native” RWR-NHBn, RWApp-NHBn and
RWGpp-NHBn. From the calculated free energies of binding and the half lifes
presented in Table 3.5 it can also be seen that the stability towards chymotryp-
tic degradation thus is sequence sensitive. RWGpp-NHBn for example was
77
3. RESULTS AND DISCUSSION
docked with a binding energy of -10.3 kcal/mol and has a half life of 4.5 hours,
whereas the confused RGppW-NHBn was calculated with a binding energy of
-6.9 kcal/mol and also found to be stable towards degradation. RAppW-NHBn
and RWApp-NHBn on the other hand were calculated with quite similar binding
energies around -9.4 kcal/mol, but RWApp-NHBn is stable whereas RAppW-
NHBn has a half life of 17 hours, indicating that the combination of App in the
S1 and W in S1’ is a better fit for hydrolysis compared with the combination of
W in S1 and App in S1’.
The calculated free energy of binding for RRW-NHBn was -6.6 kcal/mol sug-
gesting a much less favorable binding mode by changing the peptide sequence
from RWR to RRW. Docking of the peptide RRW-NHBn indicated a surpris-
ing binding mode with the central arginine residue placed in the S1 pocket of
chymotrypsin (Figure 3.16) yielding a trypsin-like activity with a bulky trypto-
phan indole in the S1’ pocket. This binding mode was also supported by the
Figure 3.16: Docking of RRW-NHBn in the active site of chymotrypsin. Both modelling
results and the degradation assay indicates that the S1 site interacts with the side chain
of arginine in an unexpected manner yielding a trypsin-like activity with a bulky trypto-
phan indole in the S1’.
degradation assay which yielded the degradation products RR and W-NHBn
with a half life of 7.2 hours. As illustrated in Figure 3.16, the P1 arginine of
RRW-NHBn in S1 is bent in an attempt to minimize the interactions with the
hydrophobic pocket in a binding mode previously described for chymotrypsin
inhibitors containing lysine [49, 173]. This highligths that while sequence rever-
sal may be employed to increase the stability, it is not always a general solution
for these compounds.
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3.4.3 Crystal structure
Molecular docking can provide important insight into the potential binding
mode of the peptides to chymotrypsin, but there is no guarantee that the compu-
tational results resemble the real binding mode. It is therefore of great interest
to obtain experimental structures of the peptide chymotrypsin complex. An ex-
perimental verified binding mode is thus of importance for further development
of the peptides with respect to stability design.
It was initially decided to try to co-crystallize the peptide with chymotrypsin
through screening different conditions such as buffers (Tris-HCl, MES, Hepes,
Sodium Cacodylate etc.), precipitants (ammonium sulfate, LiCl, PEG 3-6 K,
glycerol etc.), pHs (4-8), concentrations and temperatures (4, 20 and 37 oC).
Co-crystallization did not result in crystals, and due to the time limitation of
this project, it was in the end decided to try obtaining native chymotrypsin
crystals for doing soaking experiments.
Native crystals of α-chymotrypsin were crystallized with the hanging drop
vapor diffusion method and grew to their final size within 3-5 days (Figure
3.17). The drops consisted of protein (20-30 mg/ml) : reservoir solution (10 mM
(a) Native CHT crystals (b) Diffraction pattern
Figure 3.17: α-chymotrypsin crystals and diffraction pattern. (a) Crystals of native α-
chymotrypsin grown by the hanging drop vapor diffusion method at room temperature with drops
consisting of protein (30mg/ml):reservoir(10mM sodium cacodylate, pH 6.0, and 47% ammonium
sulfate):NaI (1M) mixed in the corresponding ratio 5µL:4µL:1µL. The well consisted of 700µL reser-
voir solution. (b) Diffraction pattern of native crystals collected with a Rigako RAXIS-IV image plate
detector.
sodium cacodylate, pH 6.0, and 44-49 % ammonium sulfate) : NaI (1M) mixed in
the corresponding ratio 5 µL : 4 µL : 1 µL. Many of the larger crystals had grown
together with other crystals, but these were quite easily separated with either
the cryo loop or a needle and still diffracted well (Figure 3.17). A reference data
set was collected on the native crystals at our home facilities to a final resolution
of 1.8 Å (data in Table 3.8). Native crystals of α-chymotrypsin (native) were
left in a soaking solution consisting of 20 mM sodium cacodylate (pH 7.4), 70%
ammonium sulfate and 3 mM tripeptide for 2-3 weeks. The crystals seemed
unaffected by the soaking solution, but dissolved in lower concentrations of
ammonium sulfate than ∼65% after a couple of days. Crystals soaked with
RWAgp-NHBn (Agp) were collected at our home facilities after 2 weeks to a
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Table 3.8: Statistics in data collection and processing
Parameter CHT structure:
Native Agpa Bipb
Overall Resolution range (Å) 40.00-1.80 38.05-2.20 35.36-1.80
Unit cell (Å) a=42.12 a=65.10 a=41.32
b=75.68 b=76.10 b=75.53
c=65.25 c=84.78 c=61.39
β = 109.41 β=108.49 β=104.44
Space group P21 P21 P21
Wavelenght (Å) 1.5418 1.5418 1.2400
No. reflections 140210 146700 147081
No. unique reflections 33936 40065 33784
Rmerge (%)c 5.5 7.7 6.3
Rmeas (%)d 6.3 9.0 7.2
Completeness (%) 94.4 100 99.7
Mean (I/σI) 9.32 5.28 8.24
Mean (I/Sd(I)) 16.69 10.40 14.68
Wilson B (Å2) 19.6 23.0 17.29
Multiplicity 4.1 3.7 4.4
Resolution of outer shell (Å) 1.80-1.89 2.32-2.20 1.90-1.80
No. of reflections 15811 21189 21480
No. of unique reflections 4299 5857 4896
Rmerge 29.2 23.3 26.4
Rmeas(%) 33.9 27.5 30.1
Completeness 81.9 100 99.9
Mean (I/σI) 2.45 3.12 2.84
Multiplicity 3.7 3.62 4.4
a Agp: CHT soaked with RWAgp-NHBn
b Bip: CHT soaked with RBipR-NHBn
cRmerge =
P P
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final resolution of 2.1 Å. Crystals soaked with RBipR-NHBn (Bip) were collected
after 3 weeks in Grenoble on the synchrotron beamline ID29 to a final resolution
of 1.8 Å. The statistics of the data collection are summarized in Table 3.8.
Native and Bip crystals belonged to the monoclinic space group P21 with
two molecules in the asymmetric unit. The Agp crystal also belonged to the
space group P21, but had 4 molecules in the asymmetric unit. The calculated
solvent content was 37, 38 and 34 % with matthew coefficients of 1.97, 1.99 and
1.89 Å3 for native, Agp and Bip, respectively. The rather low solvent content
indicate that the packing structure is rather tight in the crystals. This in turn
may make it difficult to soak the tripeptides into the active site.
The solution of the structures were obtained using the molecular replace-
ment program Phaser with Z-scores as high as 16-23, indicating clear solutions
(the boundary value for a clear solution is 8). After obtaining the solutions
from Phaser, a rigid body refinement followed by a restrained refinement was
performed with Refmac5 before the model quality was checked and adjusted
manually in Coot with the help of the electron density maps FO − FC and
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Table 3.9: Final refinement statistics
Parameter CHT structure:
Native Agp Bip
Rwork (%)a 15.9 19.8 17.6
Rfree (%)b 22.2 28.2 24.7
No. protein atoms 4096 7600 3949
No. Solvent molecules
SO2−4 2 0 0
H2O 578 584 433
Avarage B factor (Å2)
overall 18.67 17.84 19.97
Main chain 15.98 16.86 17.69
Side chain 17.79 17.90 19.95
solvent atoms 35.12 27.56 34.22
rms deviations
Bond lenghts (Å) 0.022 0.651 0.022
Bond angles (o) 1.936 1.548 1.940
Coordinate error
DPI (Å)c 0.141 0.270 0.152
Luzzati (Å) 0.156 0.256 0.180
Ramachandran plot:
Res. in favored regions (%) 98.5 95.9 96.8
Res. in allowed regions (%) 1.1 3.6 2.6






c Diffraction-component precision index
d Ser77 and Glu78 chain A
e Ser77 and Glu78 chain B and D
f Glu78 chain A and Ser77 and Glu78 chain B
2F0 − FC . The native structure was refined with Refmac5 after manually in-
troducing changes in Coot in a iterative procedure to a final Rwork of 15.9 and
the Rfree of 22.2. The ramachandran plot of the native chymotrypsin crystal
structure (Figure 3.18 a) shows that the overall geometry is good with 98.5 %
in favored regions and only 0.4 % in outlier regions (Ser77 and Glu78). By com-
paring the crystal structure with PDB entry 1t8o it was found that the overall
geometry was very similar with a calculated RMSD between the structures of
0.954 (Figure 3.18 b). As can be seen from Figure 3.18, it is the expected loop
regions that are differing the most, whereas the core and secondary elements
are conserved.
From the inspection of the electron density maps in Coot it became clear
that there were no signs of RWAgp-NHBn or RBipR-NHBn in the active site
of chymotrypsin from the soaking experiments. Chymotrypsin is a well-studied
protein and additional efforts to improve the statistics were not made without
the peptide in the active site. As previously mentioned, the crystal packing
structures are rather tight, and this might be one reason for the soaking to
fail. Crystallization and soaking conditions involved very high concentrations
of ammonium sulfate and the sulfate anions may interact with the cationic pep-
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Figure 3.18: a) Ramachandran plot of native α-chymotrypsin. b) Superimposition of
backbone between crystal structure of native α-chymotrypsin (green color) and PDB
entry code 1t8o (grey color) with an RMSD of 0.954.
tides making it difficult for them to interact with the protein and the active
site. Interestingly, crystals of native chymotrypsin grew easily, but trying to
co-crystalline around the same conditions gave no crystals. The drops stayed
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either clear, or with increased concentrations of ammonium sulfate it precipi-
tated. It thus seems that ammonium sulfate is a bad choice for crystallization
experiments with these cationice tripeptides. This indicates that future crystal-
lization experiments should screen with uncharged precipitants such as PEG,
since salts may interfere with the cationic tripeptides.
83
3. RESULTS AND DISCUSSION




4.1 Face flipping, a membrane destabilizing prop-
erty
From the molecular dynamic simulations of the tripeptides in solvent it was
found that the peptides exhibit 2-3 stable conformations where at least one
is amphipathic. These conformations were further found to be equally stable
based on the low energy differences between them. Visual inspection of the
corresponding trajectories shows that the peptides stay in one conformation
and rapidly undergoes a complete structural rearrangement yielding the second
conformation. The peptides thus switch between stable conformations that
are amphipathic and non-amphipathic, a property introduced as face flipping.
The dynamic flexibility between equally stable peptide conformations may be
a reason why geometry optimization with DFT fails when including solvent
(continuum). It was thus suspected based on the energies that something within
the cavity generation failed during the optimization.
Tripeptides with two bulky groups (Bn as capping group) display a more
distinct difference in structure, and face flipping is consequently most prominent
for these peptides. Interstingly, the MIC values (Table 3.4) also show that
peptides with benzyl as the C-terminal capping group are far more efficient
than those with an amide group as C-terminal. The face flipping property
was based on these findings proposed as a potential mechanism for membrane
interaction.
Peptide membrane interactions were studied with MD simulations using a
POPE membrane as model system. By starting the simulation with the peptide
placed outside the membrane, it was possible to examine the mechanism of how
the peptide approaches and enters the membrane. The simulations indicate that
the peptides indeed do perform the face flipping mechanism as they enter the
membrane. All the studied peptides successfully inserted the benzyl group of the
C-terminal into the membrane bilayer (around 10 ns), but not all managed to
perform the complete face flipping mechanism to get both hydrophobic groups
into the membrane within the 50 ns simulation time. It might be speculated in
that this is the reason why peptides with -NHBn as C-terminal capping group
are more efficient than those with the polar -NH2, since it seems that the benzyl
group enters the membrane more easily compare with the central X bulk (Figure
2.1).
Ideally the membrane system used for the MD simulations should have been
composed as a mix of several other phospholipids such as PG, DPG, and L-
lysl PG in order to represent a more realistic bacterium membrane (see Table
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1.2). Due to time limitations this was not possible to accomplish in the context
of this project, and must thus be studied in more detail in future projects.
The results from the membrane simulations must therefore be considered as
a preliminary study of the CAPs membrane interaction mechanism based on
the face flipping property. However, the simulations provide strong support to
the hypothesis that the peptides perform the face flipping mechanism as they
enter the membrane. Based on these preliminary studies it is suggested that
the CAPs switch between amphipathic and non-amphipathic conformations in
order to break through the polar membrane surface. Once the hydrophobic
residues are inserted into the membrane the peptide stay more or less in the
amphipathic conformation. This has also been confirmed by recent unpublished
NMR data that show more interaction between the C-terminal capping and the
hydrophobic X-group, suggesting amphipathic dominans.
4.2 A refined pharmacophore for antimicrobial
activity
The included CAPs in this project, except from RWR-NH2, fulfill the previous
reported minimum motif (two cationic charges and two hydrophobic bulk) for
antimicrobial activity, but the reported MIC values (Table 3.4) varies a lot. By
comparing the available MIC values with the calculated peptide properties it
was found that the ratio between the peptide hydrophilic and the hydrophobic
surface accessible surface area seems to play an important role in determining
the peptide antimicrobial properties. The total surface accessible volume was
also found to correlate strongly with the MIC values. RTbtR-NHBn has MIC
values superior to the other peptides, and is also the CAP in this study with both
the largest volume and the largest hydrophobic surface area (approximately 71%
of the total solvent accessible surface area). RWR-NH2 is the only peptide that
display no antimicrobial activity against S. aurerus or MRSA, and interestingly
it has both the smallest volume and the smallest hydrophobic part of the solvent
accessible surface area (48%).
A refined minimum pharmacophore for antimicrobial activity is in light of
these results suggested. A minimum motif consisting of cationic charges, a
hydrophobic surface accessible area larger than 50% and a solvent accessible
volume greater than ∼1500 Å3 seem to be required for these small peptides to
display antimicrobial properties. The cationic charges are required for inter-
action with the anionic parts of the bacterial cell membrane, and thus act as
an attracting force between CAP and membrane. A large hydrophobic solvent
accessible surface area seem to be important as it is not energetically favorable
for large hydrophobic residues to be exposed to the polar environment of the
solvent. It is therefore energetically favorable to bury these residues in the hy-
drophobic membrane. Larger peptide volumes seem to be important as they
may have a more disrupting effect on the cell membrane, e.g taking more space.
It may also be speculated in the requirement for peptide flexibility. Face flip-
ping might be required for the CAPs to enter and potentially destabilize a cell
membrane properly, and this dynamic property could therefore also be included
in the refined pharmacophore.
86
4. CONCLUDING REMARKS
4.3 Tripeptides with chymotryptic stability
Through extensive studies, combining molecular docking and ITC with experi-
mental half life assays and MIC values, it has become clear that the interactions
between the tested short antibacterial peptides and the chymotrypsin subsites
S1, S1’ and S2’ can all be used to tune the proteolytic stability while maintain-
ing a high antibacterial activity. For the S1 pocket, the bulk provided by Dip,
Bip and Tbt are sufficient for stability which opens for significant freedom in
peptide design. It has also been shown that the stability of peptides containing
arginine analogs as S1’ binders invoke a dramatic increase in the stability when
including short cationic side chains. Through residue specific interaction studies
between similar peptides with arginine analogs and chymotrypsin, it has been
suggested that Coulombic interactions with the main chain carbonyls of Phe41
and Cys58, both part of the S1’ pocket, play an important role with respect
to peptide stability. CAPs displaying a stronger interaction with Cys58 than
with Phe41 was found to be hydrolyzed, whereas those that did no were stable.
Bulky C-terminal capping groups, that are essential for activity, act as an addi-
tional residue and lowers the stability due to substrate stabilizing interactions
with S2’. It was also found that interactions with the S1’ pocket were altered as
a result of the enhanced S2’ interactions in favor of Cys58 leading to instability.
Collectively the S1, S1’ and S2’ interactions represent important findings
that allows for the design of short stable peptides, inhibitors and peptidomimics.
In addition to these more readily applicable findings it also provides fundamental
insights into the structural determinants of several unnatural amino acid side
chains and into the nature of the active site of chymotrypsin.
4.4 Further work & development
The overall goals of this project were to identify tripeptides with antimicrobial
properties exhibiting stability towards chymotryptic degradation and to inves-
tigate the potential peptide membrane interaction mechanism. The new and
detailed insight into the peptide interactions with the S1, S1’ and S2’ pock-
ets of chymotrypsin should be used for further development of potential CAPs
with a proteolytic stability design. Similar studies should also be done on other
potential peptide degrading enzymes in order to design a potent drug for oral
administration. An experimental structure of the peptide binding mode in the
active site of chymotrypsin has still not been obtained. This is of utmost im-
portance for verifying the docking results and in general the reliability of the
docking algorithm. The search for the right crystallization conditions should
therefore be continued to complete the structural study.
The peptide membrane interactions were studied with molecular dynamics
simulations using a POPE membrane as model system. However, in order to
simulate a realistic bacterial membrane, more complex model membranes should
be used. Future projects should investigate the peptide membrane interactions
using model systems resembling the phospholipid composition found in more
specific bacteria. Knowing that the membrane composition varies from one
organism to another, detailed interaction studies could ultimately be used to
fine tune the CAPs towards specific bacteria species. Future computational
studies should also be combined with experimental studies, such as NMR, in
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order to verify the simulations.
It has also been suggested that the minimum motif for antimicrobial activity
consisting of two cationic charges and two hydrophobic bulk residues is not a
very accurate definition based on the MIC values included in this project. Future
work should include larger libraries of antimicrobial peptides with available MIC
values in order to further refine the new pharmacophore suggested from this
project. The MIC values for the CAPs vary between different bacteria, and this
in turn may ultimately lead to pharmacophores for antimicrobial properties fine
tuned towards more specific species.
“The most exciting phrase to hear in science, the one that heralds new discoveries, is not
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